<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><front><journal-meta><journal-id journal-id-type="nlm-ta">Neuropsychiatr Dis Treat</journal-id><journal-id journal-id-type="iso-abbrev">Neuropsychiatr Dis Treat</journal-id><journal-id journal-id-type="pmc-domain-id">503</journal-id><journal-id journal-id-type="pmc-domain">neurodist</journal-id><journal-id journal-id-type="publisher-id">ndt</journal-id><journal-title-group><journal-title>Neuropsychiatric Disease and Treatment</journal-title></journal-title-group><issn pub-type="ppub">1176-6328</issn><issn pub-type="epub">1178-2021</issn><publisher><publisher-name>Dove Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC7910105</article-id><article-id pub-id-type="pmcid-ver">PMC7910105.1</article-id><article-id pub-id-type="pmcaid">7910105</article-id><article-id pub-id-type="pmcaiid">7910105</article-id><article-id pub-id-type="pmid">33654401</article-id><article-id pub-id-type="doi">10.2147/NDT.S268360</article-id><article-id pub-id-type="publisher-id">268360</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Original Research</subject></subj-group></article-categories><title-group><article-title>Risk of Psychiatric Disorders in Multiple Sclerosis: A Nationwide Cohort Study in an Asian Population</article-title><alt-title alt-title-type="running-authors">Huang et al</alt-title><alt-title alt-title-type="running-title">Huang et al</alt-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Huang</surname><given-names initials="YC">Yao-Ching</given-names></name><xref ref-type="aff" rid="aff0001"><sup>1</sup></xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Chien</surname><given-names initials="WC">Wu-Chien</given-names></name><xref ref-type="aff" rid="aff0002"><sup>2</sup></xref><xref ref-type="aff" rid="aff0003"><sup>3</sup></xref><xref ref-type="aff" rid="aff0004"><sup>4</sup></xref><xref ref-type="aff" rid="aff0005"><sup>5</sup></xref><xref ref-type="author-notes" rid="ft0001">*</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-4576-9900</contrib-id><name name-style="western"><surname>Chung</surname><given-names initials="CH">Chi-Hsiang</given-names></name><xref ref-type="aff" rid="aff0002"><sup>2</sup></xref><xref ref-type="aff" rid="aff0003"><sup>3</sup></xref><xref ref-type="aff" rid="aff0004"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Chang</surname><given-names initials="HA">Hsin-An</given-names></name><xref ref-type="aff" rid="aff0006"><sup>6</sup></xref><xref ref-type="aff" rid="aff0007"><sup>7</sup></xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kao</surname><given-names initials="YC">Yu-Chen</given-names></name><xref ref-type="aff" rid="aff0006"><sup>6</sup></xref><xref ref-type="aff" rid="aff0008"><sup>8</sup></xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wan</surname><given-names initials="FJ">Fang-Jung</given-names></name><xref ref-type="aff" rid="aff0006"><sup>6</sup></xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-9304-3418</contrib-id><name name-style="western"><surname>Huang</surname><given-names initials="SH">Shi-Hao</given-names></name><xref ref-type="aff" rid="aff0001"><sup>1</sup></xref></contrib><contrib contrib-type="author" equal-contrib="yes"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-0655-3680</contrib-id><name name-style="western"><surname>Chung</surname><given-names initials="RJ">Ren-Jei</given-names></name><xref ref-type="aff" rid="aff0001"><sup>1</sup></xref><xref ref-type="author-notes" rid="ft0001">*</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-4317-2940</contrib-id><name name-style="western"><surname>Wang</surname><given-names initials="RS">Richard S</given-names></name><xref ref-type="aff" rid="aff0009"><sup>9</sup></xref></contrib><contrib contrib-type="author" equal-contrib="yes"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-9910-9804</contrib-id><name name-style="western"><surname>Wang</surname><given-names initials="BL">Bing-Long</given-names></name><xref ref-type="aff" rid="aff0002"><sup>2</sup></xref><xref ref-type="corresp" rid="an0002"/><xref ref-type="author-notes" rid="ft0001">*</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-5881-7089</contrib-id><name name-style="western"><surname>Tzeng</surname><given-names initials="NS">Nian-Sheng</given-names></name><xref ref-type="aff" rid="aff0007"><sup>7</sup></xref><xref ref-type="aff" rid="aff0008"><sup>8</sup></xref><xref ref-type="corresp" rid="an0001"/><xref ref-type="author-notes" rid="ft0001">*</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Sun</surname><given-names initials="CA">Chien-An</given-names></name><xref ref-type="aff" rid="aff0010"><sup>10</sup></xref><xref ref-type="aff" rid="aff0011"><sup>11</sup></xref></contrib><aff id="aff0001"><label>1</label>Department of Chemical Engineering and Biotechnology, <institution>National Taipei University of Technology</institution>, <addr-line>Taipei</addr-line>, <country>Taiwan</country></aff><aff id="aff0002"><label>2</label><institution>School of Public Health, National Defense Medical Center</institution>, <addr-line>Taipei</addr-line>, <country>Taiwan</country></aff><aff id="aff0003"><label>3</label>Department of Medical Research, <institution>Tri-Service General Hospital, National Defense Medical Center</institution>, <addr-line>Taipei</addr-line>, <country>Taiwan</country></aff><aff id="aff0004"><label>4</label><institution>Taiwanese Injury Prevention and Safety Promotion Association</institution>, <addr-line>Taipei</addr-line>, <country>Taiwan</country></aff><aff id="aff0005"><label>5</label><institution>Graduate Institute of Life Sciences, National Defense Medical Center</institution>, <addr-line>Taipei</addr-line>, <country>Taiwan</country></aff><aff id="aff0006"><label>6</label>Department of Psychiatry, <institution>Tri-Service General Hospital, School of Medicine, National Defense Medical Center</institution>, <addr-line>Taipei</addr-line>, <country>Taiwan</country></aff><aff id="aff0007"><label>7</label><institution>Student Counseling Center, National Defense Medical Center</institution>, <addr-line>Taipei</addr-line>, <country>Taiwan</country></aff><aff id="aff0008"><label>8</label>Department of Psychiatry, <institution>Tri-Service General Hospital, Song-Shan Branch, National Defense Medical Center</institution>, <addr-line>Taipei</addr-line>, <country>Taiwan</country></aff><aff id="aff0009"><label>9</label><institution>Program of Data Analytic and Business Computing, Stern School of Business, New York University</institution>, <country>USA</country></aff><aff id="aff0010"><label>10</label>Department of Public Health, <institution>College of Medicine, Fu-Jen Catholic University</institution>, <addr-line>New Taipei City</addr-line>, <country>Taiwan</country></aff><aff id="aff0011"><label>11</label><institution>Big Data Research Center, College of Medicine, Fu-Jen Catholic University</institution>, <addr-line>New Taipei City</addr-line>, <country>Taiwan</country></aff></contrib-group><author-notes><corresp id="an0001">Correspondence: Nian-Sheng Tzeng <institution>Department of Psychiatry, School of Medicine, Tri-Service General Hospital, National Defense Medical Center</institution>, <addr-line>325, Section 2, Cheng-Gung Road, Nei-Hu District</addr-line>, <addr-line>Taipei</addr-line>, <country>Taiwan, Republic of China</country><phone>Tel +886-2-87923311 Ext 17484</phone><fax>Fax +886-2-87927221</fax> Email pierrens@mail.ndmctsgh.edu.tw</corresp><corresp id="an0002">Bing-Long Wang <institution>Department of Public Health, National Defense Medical Center</institution>, <addr-line>116, Section 6, Minchuan E. Road, Nei-Hu District</addr-line>, <addr-line>Taipei</addr-line>, <country>Taiwan, Republic of China</country><phone>Tel +886-980-794951</phone> Email billwang1203@gmail.com</corresp><fn id="ft0001"><label>*</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date pub-type="epub"><day>22</day><month>2</month><year>2021</year></pub-date><pub-date pub-type="collection"><year>2021</year></pub-date><volume>17</volume><issue-id pub-id-type="pmc-issue-id">372608</issue-id><fpage>587</fpage><lpage>604</lpage><history><date date-type="received"><day>23</day><month>9</month><year>2020</year></date><date date-type="accepted"><day>18</day><month>1</month><year>2021</year></date></history><pub-history><event event-type="pmc-release"><date><day>22</day><month>02</month><year>2021</year></date></event><event event-type="pmc-live"><date><day>01</day><month>03</month><year>2021</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2021-03-03 15:16:24.240"><day>03</day><month>03</month><year>2021</year></date></event></pub-history><permissions><copyright-statement>&#169; 2021 Huang et al.</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Huang et al.</copyright-holder><license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/"><license-p>This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at <ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/terms.php">https://www.dovepress.com/terms.php</ext-link> and incorporate the Creative Commons Attribution &#8211; Non Commercial (unported, v3.0) License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (<ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/terms.php">https://www.dovepress.com/terms.php</ext-link>).</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="ndt-17-587.pdf"/><abstract><sec id="s2001"><title>Background</title><p>Multiple sclerosis (MS) is a demyelinating disease that can damage neurons in the brain and spinal cord and is associated with several psychiatric disorders. However, few studies have evaluated the risk of psychiatric disorders in patients with MS by using a nationwide database. This study investigated the association between MS and the risk of psychiatric disorders.</p></sec><sec id="s2002"><title>Methods</title><p>Using data from the Taiwan National Health Insurance Research Database from 2000 to 2015, we identified 1066 patients with MS. After adjustment for confounding factors, Fine and Gray&#8217;s competing risk model was used to compare the risk of psychiatric disorders during 15 years of follow-up.</p></sec><sec id="s2003"><title>Results</title><p>Of the patients with MS, 531 (4622.86 per 10<sup>5</sup> person years) developed psychiatric disorders; by contrast, 891 of the 3198 controls (2485.31 per 10<sup>5</sup> person years) developed psychiatric disorders. Fine and Gray&#8217;s competing risk model revealed an adjusted hazard ratio (HR) of 5.044 (95% confidence interval = 4.448&#8211;5.870, <italic toggle="yes">p</italic> &lt; 0.001) after adjustment for all the covariates. MS was associated with depression, anxiety, bipolar disorder, sleep disorders, schizophrenia, schizophreniform disorder, and other psychotic disorders (adjusted HR: 12.464, 4.650, 6.987, 9.103, 2.552, 2.600, 2.441, and 2.574, respectively; all p &lt; 0.001). Some disease-modifying drugs were associated with a lower risk of anxiety or depression.</p></sec><sec id="s2004"><title>Conclusion</title><p>Patients with MS were determined to have a higher risk of developing a wide range of psychiatric disorders.</p></sec></abstract><kwd-group kwd-group-type="author"><title>Keywords</title><kwd>multiple sclerosis</kwd><kwd>psychiatric disorders</kwd><kwd>depression</kwd><kwd>anxiety</kwd></kwd-group><counts><fig-count count="4"/><table-count count="11"/><ref-count count="95"/><page-count count="18"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="s0001"><title>Introduction</title><p>Although patients with multiple sclerosis (MS) experience considerable challenges and even disability, comprehension of the underlying factors of this disease, including genetics and environmental conditions, has improved.<xref rid="cit0001" ref-type="bibr">1</xref> MS often has negative effects on the patients&#8217; quality of life as well as their interpersonal relationships, employment, and social life.<xref rid="cit0002" ref-type="bibr">2</xref> Neuroimaging research have revealed that symptoms can originate from different brain networks, regardless of the pathological substrate, and from disconnections caused by damage to the strategic white matter tracts.<xref rid="cit0003" ref-type="bibr">3</xref></p><p>Previous studies have found that some neuropsychiatric disorders are associated with several immune-mediated inflammatory diseases,<xref rid="cit0004" ref-type="bibr">4</xref> such as Guillain-Barre syndrome,<xref rid="cit0005" ref-type="bibr">5</xref> fibromyalgia,<xref rid="cit0006" ref-type="bibr">6</xref> allergic diseases,<xref rid="cit0007" ref-type="bibr">7</xref> and periodontal inflammatory diseases.<xref rid="cit0008" ref-type="bibr">8&#8211;11</xref> Psychological stressors related to the inflammatory diseases might also contribute to both psychiatric and physical morbidity,<xref rid="cit0012" ref-type="bibr">12</xref> and several studies have found that MS is associated with depression, anxiety, bipolar disorder, sleep disorders, alcohol abuse, substance abuse, and psychosis.<xref rid="cit0013" ref-type="bibr">13</xref>,<xref rid="cit0014" ref-type="bibr">14</xref> However, in Taiwan, the prevalence of MS is approximately 2&#8211;5 per 100,000,<xref rid="cit0015" ref-type="bibr">15&#8211;17</xref> which is much lower than the 10-year prevalence of MS in the United States (149.2&#8211;309.2 per 100,000).<xref rid="cit0018" ref-type="bibr">18</xref>,<xref rid="cit0019" ref-type="bibr">19</xref> Most of the studies about the association between multiple sclerosis and psychiatric disorders are from Western countries, with higher MS prevalence, including anxiety, depression, bipolar disorder, sleep disorder, alcohol abuse, drug abuse, and psychotic disorder, such as schizophrenia.<xref rid="cit0004" ref-type="bibr">4</xref>,<xref rid="cit0013" ref-type="bibr">13</xref>,<xref rid="cit0014" ref-type="bibr">14</xref>,<xref rid="cit0020" ref-type="bibr">20&#8211;23</xref> Other studies have reported that patients with MS to be at risk for some psychiatric disorders including depression<xref rid="cit0024" ref-type="bibr">24</xref> and erectile dysfunction,<xref rid="cit0025" ref-type="bibr">25</xref> but no nationwide population-based study has yet been conducted on the correlations of MS with most of the other aforementioned psychiatric disorders. Therefore, a nationwide cohort study must be executed to determine the association of MS with psychiatric disorders in Taiwan. This explored this topic by applying National Health Insurance Research Database (NHIRD)-derived data in order to determine the psychiatric morbidity of patients with MS in Taiwan.</p></sec><sec id="s0002"><title>Methods</title><sec id="s0002-s2001"><title>Data Sources</title><p>The National Health Insurance (NHI) program, which is Taiwan&#8217;s single-payer insurance system, was launched in 1995. As of June 2018, it provided medical coverage for an estimated 23 million individuals (&gt;99% of the population in Taiwan), in collaboration with 97% of medical providers.<xref rid="cit0026" ref-type="bibr">26</xref>,<xref rid="cit0027" ref-type="bibr">27</xref> Previously executed research has documented the program&#8217;s details.<xref rid="cit0028" ref-type="bibr">28&#8211;40</xref></p><p>The NHIRD comprises comprehensive data on patients&#8217; sex and their date of birth as well as the prescriptions, dental care, outpatient care, and inpatient care that they have received. In accordance with the Personal Information Protection Act, patient identifiers undergo encryption prior to the release of data for use in research. NHIRD-recorded diagnoses are coded in accordance with the International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM). Board-certified neurologists and board-certified psychiatrists gave all MS diagnoses and all psychiatric disorder diagnoses, respectively. In Taiwan, the diagnosis of MS was according to the McDonald criteria and serial of the revised versions.<xref rid="cit0041" ref-type="bibr">41&#8211;43</xref></p><p>In the present study, inpatients determined to have received an MS diagnosis (ICD-9-CM code: 340) at discharge during 2000&#8211;2015 were identified from the 2-million Longitudinal Health Insurance Database, a subset of the NHIRD. Clinic and hospital reimbursement claims were reviewed by licensed medical record technicians for coding verification.<xref rid="cit0027" ref-type="bibr">27</xref> Senior external specialists in psychiatry and neurology are selected by the National Health Insurance Administration (NHIA) to periodically conduct random reviews of records pertaining to outpatient care visits as well as inpatient claims in order to confirm accurate diagnoses.<xref rid="cit0044" ref-type="bibr">44</xref></p></sec><sec id="s0002-s2002"><title>Study Design and Sampling</title><p>In our executed population-based, matched-cohort study, we identified from the inpatient data set adults who had recently received an MS diagnosis during the period from January 1, 2000, to December 31, 2015. To restrict our sample to only patients with newly registered MS, we excluded patients who had received an MS diagnosis prior to 2000. Additionally, patients who had received a diagnosis of depressive, bipolar, anxiety, sleep, schizophrenia, schizophreniform disorder, other psychotic disorder, or substance-related disorders (disorders pertaining to alcohol use or illicit drug use) before 2000 were excluded. All patients under the age of 20 years were also excluded so that that only adult patients were included. The patients&#8217; catastrophic illness certificates (CICs) were used to ensure the accuracy of the MS diagnosis because in accordance with NHI regulations, patients with a CIC are exempted from copayment for MS&#8208;related medical care after their medical records and imaging and laboratory results have been rigorously reviewed. With reference to other research involving the use of the NHIRD to study MS, we estimated patients&#8217; follow-up durations by using CIC registration dates as the index dates.<xref rid="cit0045" ref-type="bibr">45</xref> The NHIA review committee assesses applications according to both the Posner criteria and McDonald criteria.<xref rid="cit0046" ref-type="bibr">46</xref> Among the patients included in this study, the average time from the first inpatient diagnosis to the CIC registration date was 14.06 (standard deviation [SD] = 18.25) days. We excluded patients who had other neurological disorders and were admitted due to conditions that were comparable to MS, including critical illness polyneuropathy, chronic inflammatory demyelinating polyneuropathy, polyneuropathy caused by other diseases (eg, diphtheria or porphyria), critical illness myopathy, acute poliomyelitis, myasthenic syndromes, myasthenia gravis, acute transverse myelitis, or poisoning from drugs or biological substances (<xref ref-type="fig" rid="f0001">Figure 1</xref>).<fig id="f0001" fig-type="figure" orientation="portrait" position="float"><label>Figure 1</label><caption><p>The flowchart of study of multiple sclerosis (MS) sample selection from National Health Insurance Research Database in Taiwan.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" content-type="print-only" position="float" orientation="portrait" xlink:href="NDT-17-587-g0001.jpg"/></fig></p></sec><sec id="s0002-s2003"><title>Ethics</title><p>The tenets of the Declaration of Helsinki were adhered to, following the Code of Ethics of the World Medical Association. Since the identifiable database of individuals included in the NHIRD were all encrypted in order to protect individual privacy,<xref rid="cit0027" ref-type="bibr">27</xref>,<xref rid="cit0047" ref-type="bibr">47</xref>,<xref rid="cit0048" ref-type="bibr">48</xref> the NHI Administration has given general approval for their data to be used in this research.<xref rid="cit0048" ref-type="bibr">48</xref> Because the NHIRD has the advantage of providing a large-scale, longitudinal, reliable dataset, leading to extensive usage for population-based researches in Taiwan.<xref rid="cit0048" ref-type="bibr">48&#8211;51</xref> Therefore, the Tri-Service General Hospital&#8217;s Institutional Review Board ratified our executed study (IRB No. 2-107-05-026); in addition, the necessity of written informed consent from individuals was waived.</p></sec><sec id="s0002-s2004"><title>Covariates</title><p>The covariates in this study consisted of sex, age group (20&#8211;49, 50&#8211;64, or &#8805;65 years), marital status, education (&lt;12 years or &#8805;12 years), monthly income (&lt;NT$18,000, NT$18,000&#8211;34,999, &#8805;NT$35,000), urbanization level (levels 1&#8211;4), and region of residence (central, northern, eastern, or southern Taiwan). Population as well as several indicators of development level constituted the basis for the definition of urbanization level; the definition is detailed as follows. Level 1: population of &gt;1,250,000 with designated economic, political, metropolitan, and cultural development. Level 2: population of 500,000&#8211;1,249,999 with prominent political, cultural, and economic influence. Level 3: population of 149,999&#8211;499,999. Level 4: population of &lt;149,999. Usage of the NHI-reimbursed disease-modifying drugs (DMDs) that include, natalizumab, interferon &#946;-1a, interferon &#946;-1b, and teriflunomide were also recorded.</p></sec><sec id="s0002-s2005"><title>Comorbidity</title><p>Comorbidities in this study included the following: coronary artery, peripheral vascular, chronic pulmonary, cerebrovascular, peptic ulcer, rheumatologic, liver, and renal diseases. Other comorbidities included were diabetes mellitus, hemiplegia or paraplegia, malignancy, metastatic solid tumor, congestive heart failure, myocardial infarction, acquired immune deficiency syndrome/human immunodeficiency virus, infectious mononucleosis, hypertension, hyperlipidemia, lower leg fracture or surgery, systemic lupus erythematosus, rheumatoid arthritis, deficiency anemias, fluid or electrolyte disorders, smoking habit, and obesity. The reasons for the inclusion of these comorbidities in this analysis were that they are either clinical risk factors for MS, or have been suspected of being associated with development of MS.<xref rid="cit0022" ref-type="bibr">22</xref>,<xref rid="cit0052" ref-type="bibr">52&#8211;56</xref>
<underline><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.dovepress.com/get_supplementary_file.php?f=268360.docx">Table S1</ext-link></underline> lists all the ICD-9-CM codes for these comorbidities.</p></sec><sec id="s0002-s2006"><title>Outcome Measures</title><p>Psychiatric, or mental disorders, are defined as clinically significant behavioral or psychological syndromes, which are associated with present distress, disability, or an increased risk of suffering death, pain, or disability, and subsequent behavioral, psychological, or biological dysfunctions.<xref rid="cit0057" ref-type="bibr">57</xref>,<xref rid="cit0058" ref-type="bibr">58</xref> The included patients were all followed from the index date until the occurrence of any of the following events: onset of anxiety, depressive, bipolar, sleep, schizophrenia, schizophreniform disorder, other psychotic disorder, or substance-related (namely alcohol use or illicit drug use) disorders; withdrawal from the NHI program; or the end of 2015. All of the ICD-9-CM codes for the outcomes are listed in <underline><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.dovepress.com/get_supplementary_file.php?f=268360.docx">Table S1</ext-link></underline>. In this study, we have separated these diagnoses by the first identified ICD codes in the subjects in these two cohorts.</p></sec><sec id="s0002-s2007"><title>Statistical Analysis</title><p>SPSS for Windows, version 22.0 (IBM Corp., Armonk, NY, USA) was applied in this study to execute all statistical analyses. The distribution of categorical variables was assessed using the &#967;<sup>2</sup> test; in addition, that of continuous variables was determined by applying a <italic toggle="yes">t</italic> test, with the Fisher exact test. On the basis of the model presented by Fine and Gray, this study executed a survival analysis to compare estimated hazards for patients with diseases that had a potential outcome of death, such as MS, with those for the controls.<xref rid="cit0059" ref-type="bibr">59</xref> To perform this analysis, the SPSS value-added module, including competing risks survival analysis, was applied (<underline><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.asia-analytics.com.tw/en/product/p-asia-analytics-2.jsp">https://www.asia-analytics.com.tw/en/product/p-asia-analytics-2.jsp</ext-link></underline>).Accordingly, we could employ the competing risk analysis approach put forward by Fine and Gray to identify the risk of psychiatric disorders (competing with death) in patients with MS.<xref rid="cit0060" ref-type="bibr">60</xref> The results that were derived from the mentioned analysis are presented herein as hazard ratios (HRs) and their corresponding 95% confidence intervals (CIs). We compared the control and study groups with respect to the risk of psychiatric disorders by executing the Kaplan&#8211;Meier method in conjunction with a Log rank test. A two-tailed <italic toggle="yes">p</italic> value of &lt;0.05 was deemed in this study as denoting statistical significance.</p></sec></sec><sec id="s0003"><title>Results</title><sec id="s0003-s2001"><title>Sample Characteristics</title><p>As indicated in <xref rid="t0001" ref-type="table">Table 1</xref>, 1:3 matching was performed on the enrolled patients (1066 patients with MS and 3198 controls without MS) with respect to index year, sex, and age. There were statistically significant differences in hemiplegia or paraplegia, rheumatologic disease, liver disease, hyperlipidemia, lower leg fracture or surgery, systemic lupus erythematosus, deficiency anemias, and fluid and electrolyte disorders between the MS and control groups. The MS group tended to have a higher percentage of patients living in Northern or Eastern Taiwan, residing in areas with urbanization levels of 1 and 2, and seeking medical care from a medical center.<table-wrap id="t0001" orientation="portrait" position="float"><label>Table 1</label><caption><p>Characteristics of Study at the Baseline</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" colspan="1">Variables</th><th colspan="2" rowspan="1">MS Cohort</th><th colspan="2" rowspan="1">Controls</th><th rowspan="2" colspan="1"><italic toggle="yes">P</italic></th></tr><tr><th rowspan="1" colspan="1">n</th><th rowspan="1" colspan="1">%</th><th rowspan="1" colspan="1">n</th><th rowspan="1" colspan="1">%</th></tr></thead><tbody><tr><td rowspan="1" colspan="1"><bold>Total</bold></td><td rowspan="1" colspan="1">1066</td><td rowspan="1" colspan="1">25.00</td><td rowspan="1" colspan="1">3198</td><td rowspan="1" colspan="1">75.00</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><bold>Sex</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.999</td></tr><tr><td rowspan="1" colspan="1">&#8195;Male</td><td rowspan="1" colspan="1">210</td><td rowspan="1" colspan="1">19.70</td><td rowspan="1" colspan="1">630</td><td rowspan="1" colspan="1">19.70</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;Female</td><td rowspan="1" colspan="1">856</td><td rowspan="1" colspan="1">80.30</td><td rowspan="1" colspan="1">2568</td><td rowspan="1" colspan="1">80.30</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><bold>Age (years)</bold></td><td colspan="2" rowspan="1">41.20&#177;13.17</td><td colspan="2" rowspan="1">40.93&#177;14.78</td><td rowspan="1" colspan="1">0.596</td></tr><tr><td rowspan="1" colspan="1"><bold>Age group (years)</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.999</td></tr><tr><td rowspan="1" colspan="1">&#8195;20&#8211;49</td><td rowspan="1" colspan="1">788</td><td rowspan="1" colspan="1">73.92</td><td rowspan="1" colspan="1">2364</td><td rowspan="1" colspan="1">73.92</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;50&#8211;64</td><td rowspan="1" colspan="1">224</td><td rowspan="1" colspan="1">21.01</td><td rowspan="1" colspan="1">672</td><td rowspan="1" colspan="1">21.01</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;&#8807;65</td><td rowspan="1" colspan="1">54</td><td rowspan="1" colspan="1">5.07</td><td rowspan="1" colspan="1">162</td><td rowspan="1" colspan="1">5.07</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><bold>Marital status</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.868</td></tr><tr><td rowspan="1" colspan="1">&#8195;Single</td><td rowspan="1" colspan="1">812</td><td rowspan="1" colspan="1">76.17</td><td rowspan="1" colspan="1">2428</td><td rowspan="1" colspan="1">75.92</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;Married</td><td rowspan="1" colspan="1">254</td><td rowspan="1" colspan="1">23.83</td><td rowspan="1" colspan="1">770</td><td rowspan="1" colspan="1">24.08</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><bold>Education (years)</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.832</td></tr><tr><td rowspan="1" colspan="1">&#8195;&lt;12</td><td rowspan="1" colspan="1">500</td><td rowspan="1" colspan="1">46.90</td><td rowspan="1" colspan="1">1512</td><td rowspan="1" colspan="1">47.28</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;&#8807;12</td><td rowspan="1" colspan="1">566</td><td rowspan="1" colspan="1">53.10</td><td rowspan="1" colspan="1">1686</td><td rowspan="1" colspan="1">52.72</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><bold>Insurance premium (NT$)</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.996</td></tr><tr><td rowspan="1" colspan="1">&#8195;&lt;18,000</td><td rowspan="1" colspan="1">861</td><td rowspan="1" colspan="1">80.77</td><td rowspan="1" colspan="1">2579</td><td rowspan="1" colspan="1">80.64</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;18,000&#8211;34,999</td><td rowspan="1" colspan="1">139</td><td rowspan="1" colspan="1">13.04</td><td rowspan="1" colspan="1">420</td><td rowspan="1" colspan="1">13.13</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;&#8807;35,000</td><td rowspan="1" colspan="1">66</td><td rowspan="1" colspan="1">6.19</td><td rowspan="1" colspan="1">199</td><td rowspan="1" colspan="1">6.22</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><bold>Comorbidities</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;Myocardial infarction</td><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1">0.28</td><td rowspan="1" colspan="1">10</td><td rowspan="1" colspan="1">0.31</td><td rowspan="1" colspan="1">0.873</td></tr><tr><td rowspan="1" colspan="1">&#8195;Congestive heart failure</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">0.09</td><td rowspan="1" colspan="1">18</td><td rowspan="1" colspan="1">0.56</td><td rowspan="1" colspan="1">0.046</td></tr><tr><td rowspan="1" colspan="1">&#8195;Peripheral vascular disease</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">&#8211;</td></tr><tr><td rowspan="1" colspan="1">&#8195;Cerebrovascular disease</td><td rowspan="1" colspan="1">28</td><td rowspan="1" colspan="1">2.63</td><td rowspan="1" colspan="1">70</td><td rowspan="1" colspan="1">2.19</td><td rowspan="1" colspan="1">0.409</td></tr><tr><td rowspan="1" colspan="1">&#8195;Hemiplegia or paraplegia</td><td rowspan="1" colspan="1">41</td><td rowspan="1" colspan="1">3.85</td><td rowspan="1" colspan="1">12</td><td rowspan="1" colspan="1">0.38</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">&#8195;Chronic pulmonary disease</td><td rowspan="1" colspan="1">14</td><td rowspan="1" colspan="1">1.31</td><td rowspan="1" colspan="1">65</td><td rowspan="1" colspan="1">2.03</td><td rowspan="1" colspan="1">0.132</td></tr><tr><td rowspan="1" colspan="1">&#8195;Rheumatologic disease</td><td rowspan="1" colspan="1">23</td><td rowspan="1" colspan="1">2.16</td><td rowspan="1" colspan="1">24</td><td rowspan="1" colspan="1">0.75</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">&#8195;Peptic ulcer disease</td><td rowspan="1" colspan="1">31</td><td rowspan="1" colspan="1">2.91</td><td rowspan="1" colspan="1">124</td><td rowspan="1" colspan="1">3.88</td><td rowspan="1" colspan="1">0.143</td></tr><tr><td rowspan="1" colspan="1">&#8195;Diabetes</td><td rowspan="1" colspan="1">57</td><td rowspan="1" colspan="1">5.35</td><td rowspan="1" colspan="1">167</td><td rowspan="1" colspan="1">5.22</td><td rowspan="1" colspan="1">0.874</td></tr><tr><td rowspan="1" colspan="1">&#8195;Renal disease</td><td rowspan="1" colspan="1">5</td><td rowspan="1" colspan="1">0.47</td><td rowspan="1" colspan="1">16</td><td rowspan="1" colspan="1">0.50</td><td rowspan="1" colspan="1">0.899</td></tr><tr><td rowspan="1" colspan="1">&#8195;Malignancy</td><td rowspan="1" colspan="1">60</td><td rowspan="1" colspan="1">5.63</td><td rowspan="1" colspan="1">232</td><td rowspan="1" colspan="1">7.25</td><td rowspan="1" colspan="1">0.069</td></tr><tr><td rowspan="1" colspan="1">&#8195;Metastatic solid tumor</td><td rowspan="1" colspan="1">6</td><td rowspan="1" colspan="1">0.56</td><td rowspan="1" colspan="1">32</td><td rowspan="1" colspan="1">1.00</td><td rowspan="1" colspan="1">0.188</td></tr><tr><td rowspan="1" colspan="1">&#8195;Liver disease</td><td rowspan="1" colspan="1">14</td><td rowspan="1" colspan="1">1.31</td><td rowspan="1" colspan="1">158</td><td rowspan="1" colspan="1">4.94</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">&#8195;AIDS/HIV</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">0.09</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">0.083</td></tr><tr><td rowspan="1" colspan="1">&#8195;Infectious mononucleosis</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">&#8211;</td></tr><tr><td rowspan="1" colspan="1">&#8195;Hypertension</td><td rowspan="1" colspan="1">74</td><td rowspan="1" colspan="1">6.94</td><td rowspan="1" colspan="1">190</td><td rowspan="1" colspan="1">5.94</td><td rowspan="1" colspan="1">0.240</td></tr><tr><td rowspan="1" colspan="1">&#8195;Hyperlipidemia</td><td rowspan="1" colspan="1">42</td><td rowspan="1" colspan="1">3.94</td><td rowspan="1" colspan="1">13</td><td rowspan="1" colspan="1">0.41</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">&#8195;Lower leg fracture or surgery</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">0.09</td><td rowspan="1" colspan="1">65</td><td rowspan="1" colspan="1">2.03</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">&#8195;Coronary artery disease</td><td rowspan="1" colspan="1">26</td><td rowspan="1" colspan="1">2.44</td><td rowspan="1" colspan="1">81</td><td rowspan="1" colspan="1">2.53</td><td rowspan="1" colspan="1">0.865</td></tr><tr><td rowspan="1" colspan="1">&#8195;Systemic lupus erythematosus</td><td rowspan="1" colspan="1">15</td><td rowspan="1" colspan="1">1.41</td><td rowspan="1" colspan="1">9</td><td rowspan="1" colspan="1">0.28</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">&#8195;Rheumatoid arthritis</td><td rowspan="1" colspan="1">4</td><td rowspan="1" colspan="1">0.38</td><td rowspan="1" colspan="1">8</td><td rowspan="1" colspan="1">0.25</td><td rowspan="1" colspan="1">0.504</td></tr><tr><td rowspan="1" colspan="1">&#8195;Deficiency anemias</td><td rowspan="1" colspan="1">10</td><td rowspan="1" colspan="1">0.94</td><td rowspan="1" colspan="1">11</td><td rowspan="1" colspan="1">0.34</td><td rowspan="1" colspan="1">0.016</td></tr><tr><td rowspan="1" colspan="1">&#8195;Fluid and electrolyte disorders</td><td rowspan="1" colspan="1">25</td><td rowspan="1" colspan="1">2.35</td><td rowspan="1" colspan="1">12</td><td rowspan="1" colspan="1">0.38</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">&#8195;Smoking</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">&#8211;</td></tr><tr><td rowspan="1" colspan="1">&#8195;Obesity</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">0.09</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">0.083</td></tr><tr><td rowspan="1" colspan="1"><bold>Annual medical visits</bold></td><td colspan="2" rowspan="1">9.42&#177;10.12</td><td colspan="2" rowspan="1">10.01&#177;11.25</td><td rowspan="1" colspan="1">0.129</td></tr><tr><td rowspan="1" colspan="1"><bold>Location</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">&#8195;Northern Taiwan</td><td rowspan="1" colspan="1">549</td><td rowspan="1" colspan="1">51.50</td><td rowspan="1" colspan="1">1364</td><td rowspan="1" colspan="1">42.65</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;Middle Taiwan</td><td rowspan="1" colspan="1">206</td><td rowspan="1" colspan="1">19.32</td><td rowspan="1" colspan="1">845</td><td rowspan="1" colspan="1">26.42</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;Southern Taiwan</td><td rowspan="1" colspan="1">257</td><td rowspan="1" colspan="1">24.11</td><td rowspan="1" colspan="1">837</td><td rowspan="1" colspan="1">26.17</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;Eastern Taiwan</td><td rowspan="1" colspan="1">54</td><td rowspan="1" colspan="1">5.07</td><td rowspan="1" colspan="1">138</td><td rowspan="1" colspan="1">4.32</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;Outlets islands</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">0.00</td><td rowspan="1" colspan="1">14</td><td rowspan="1" colspan="1">0.44</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><bold>Urbanization level</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">&#8195;1 (The highest)</td><td rowspan="1" colspan="1">542</td><td rowspan="1" colspan="1">50.84</td><td rowspan="1" colspan="1">1233</td><td rowspan="1" colspan="1">38.56</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;2</td><td rowspan="1" colspan="1">448</td><td rowspan="1" colspan="1">42.03</td><td rowspan="1" colspan="1">1310</td><td rowspan="1" colspan="1">40.96</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;3</td><td rowspan="1" colspan="1">27</td><td rowspan="1" colspan="1">2.53</td><td rowspan="1" colspan="1">262</td><td rowspan="1" colspan="1">8.19</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;4 (The lowest)</td><td rowspan="1" colspan="1">49</td><td rowspan="1" colspan="1">4.60</td><td rowspan="1" colspan="1">393</td><td rowspan="1" colspan="1">12.29</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><bold>Level of care</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">&#8195;Medical center</td><td rowspan="1" colspan="1">786</td><td rowspan="1" colspan="1">73.73</td><td rowspan="1" colspan="1">1014</td><td rowspan="1" colspan="1">31.71</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;Regional hospital</td><td rowspan="1" colspan="1">239</td><td rowspan="1" colspan="1">22.42</td><td rowspan="1" colspan="1">1132</td><td rowspan="1" colspan="1">35.40</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;Local hospital</td><td rowspan="1" colspan="1">41</td><td rowspan="1" colspan="1">3.85</td><td rowspan="1" colspan="1">1052</td><td rowspan="1" colspan="1">32.90</td><td rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn id="tfn0001"><p><bold>Note:</bold>
<italic toggle="yes">P</italic>: Chi-square/Fisher exact test on category variables and <italic toggle="yes">t</italic>-test on continue variables.</p></fn><fn id="tfn0002"><p><bold>Abbreviations:</bold> MS, multiple sclerosis; NT$, New Taiwan Dollars; AIDS/HIV, acquired immunodeficiency syndrome/human immunodeficiency virus infection.</p></fn></table-wrap-foot></table-wrap>
</p></sec><sec id="s0003-s2002"><title>Cumulative Risk of Psychiatric Disorders as Assessed Using the Kaplan&#8211;Meier Model</title><p>Of the MS patients, 531 (4622.86 per 10<sup>5</sup> person years) were determined to develop psychiatric disorders; by contrast, whereas 891 of the 3198 individuals in the control group (2,85.31 per 10<sup>5</sup> person years) were determined to develop psychiatric disorders. This difference reached statistical significance, as determined through the execution of Kaplan&#8211;Meier survival analysis (log rank, <italic toggle="yes">p</italic> &lt; 0.001, <xref ref-type="fig" rid="f0002">Figure 2</xref>).<fig id="f0002" fig-type="figure" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Kaplan&#8211;Meier for cumulative incidence of psychiatric disorders aged 20 and over stratified by multiple sclerosis (MS) with Log rank test.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" content-type="print-only" position="float" orientation="portrait" xlink:href="NDT-17-587-g0002.jpg"/></fig></p></sec><sec id="s0003-s2003"><title>HR for Psychiatric Disorders in MS Group</title><p><xref rid="t0002" ref-type="table">Table 2</xref> presents the results derived from the analysis executed using the competing risk model. As revealed by the table, the MS group was determined to exhibit a higher likelihood of developing psychiatric disorders when compared with the control group (crude HR: 4.407; 95% CI = 3.918&#8211;5.087, <italic toggle="yes">p</italic> &lt; 0.001). Moreover, the results indicated that after sex, monthly income, urbanization level, geographic region, comorbidities, and age were adjusted for, the adjusted HR was 5.044 (95% confidence interval = 4.448&#8212;5.870, <italic toggle="yes">p</italic> &lt; 0.001). The results suggested that patients in the MS group who had CCI scores of 2 to 4 and who received medical care from a regional hospital or medical center exhibited a higher risk of psychiatric disorders. Male patients exhibited a lower risk.<table-wrap id="t0002" orientation="landscape" position="float"><label>Table 2</label><caption><p>Factors of Psychiatric Disorders by Using Fine and Gray&#8217;s Competing Risk Model</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" colspan="1">Variables</th><th colspan="8" rowspan="1">Competing Risk in the Model</th></tr><tr><th rowspan="1" colspan="1">Crude SHR</th><th rowspan="1" colspan="1">95% CI</th><th rowspan="1" colspan="1">95% CI</th><th rowspan="1" colspan="1"><italic toggle="yes">P</italic></th><th rowspan="1" colspan="1">Adjusted SHR</th><th rowspan="1" colspan="1">95% CI</th><th rowspan="1" colspan="1">95% CI</th><th rowspan="1" colspan="1"><italic toggle="yes">P</italic></th></tr></thead><tbody><tr><td rowspan="1" colspan="1"><bold>Multiple sclerosis</bold> (reference: without)</td><td rowspan="1" colspan="1">4.407</td><td rowspan="1" colspan="1">3.918</td><td rowspan="1" colspan="1">5.087</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">5.044</td><td rowspan="1" colspan="1">4.448</td><td rowspan="1" colspan="1">5.870</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td colspan="9" rowspan="1"><bold>Psychiatric diagnoses with multiple sclerosis (531/1066, 4.622.86 per 10<sup>5</sup> person-years)</bold></td></tr><tr><td colspan="9" rowspan="1"><bold>Psychiatric diagnoses without multiple sclerosis (891/3198, 2.485.31 per 10<sup>5</sup> person-years)</bold></td></tr><tr><td rowspan="1" colspan="1"><bold>Male</bold> (reference: female)</td><td rowspan="1" colspan="1">0.763</td><td rowspan="1" colspan="1">0.673</td><td rowspan="1" colspan="1">0.891</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">0.875</td><td rowspan="1" colspan="1">0.767</td><td rowspan="1" colspan="1">0.995</td><td rowspan="1" colspan="1">0.045</td></tr><tr><td rowspan="1" colspan="1"><bold>Peripheral vascular disease</bold> (reference: without)</td><td rowspan="1" colspan="1">8.385</td><td rowspan="1" colspan="1">2.082</td><td rowspan="1" colspan="1">34.665</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">5.359</td><td rowspan="1" colspan="1">1.309</td><td rowspan="1" colspan="1">22.518</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1"><bold>Cerebrovascular disease</bold> (reference: without)</td><td rowspan="1" colspan="1">1.650</td><td rowspan="1" colspan="1">1.338</td><td rowspan="1" colspan="1">2.089</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">1.470</td><td rowspan="1" colspan="1">1.163</td><td rowspan="1" colspan="1">1.906</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1"><bold>Chronic pulmonary disease</bold> (reference: without)</td><td rowspan="1" colspan="1">1.808</td><td rowspan="1" colspan="1">1.433</td><td rowspan="1" colspan="1">2.341</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">1.917</td><td rowspan="1" colspan="1">1.504</td><td rowspan="1" colspan="1">2.510</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1"><bold>Peptic ulcer disease</bold> (reference: without)</td><td rowspan="1" colspan="1">1.778</td><td rowspan="1" colspan="1">1.446</td><td rowspan="1" colspan="1">2.244</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">1.604</td><td rowspan="1" colspan="1">1.294</td><td rowspan="1" colspan="1">2.040</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1"><bold>Diabetes mellitus</bold> (reference: without)</td><td rowspan="1" colspan="1">1.690</td><td rowspan="1" colspan="1">1.454</td><td rowspan="1" colspan="1">2.015</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">1.555</td><td rowspan="1" colspan="1">1.321</td><td rowspan="1" colspan="1">1.879</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1"><bold>Renal disease</bold> (reference: without)</td><td rowspan="1" colspan="1">3.407</td><td rowspan="1" colspan="1">2.511</td><td rowspan="1" colspan="1">4.744</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">3.513</td><td rowspan="1" colspan="1">2.562</td><td rowspan="1" colspan="1">4.944</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1"><bold>Liver disease</bold> (reference: without)</td><td rowspan="1" colspan="1">1.993</td><td rowspan="1" colspan="1">1.659</td><td rowspan="1" colspan="1">2.459</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">2.138</td><td rowspan="1" colspan="1">1.763</td><td rowspan="1" colspan="1">2.661</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1"><bold>Hyperlipidemia</bold> (reference: without)</td><td rowspan="1" colspan="1">2.258</td><td rowspan="1" colspan="1">1.847</td><td rowspan="1" colspan="1">2.833</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">1.751</td><td rowspan="1" colspan="1">1.404</td><td rowspan="1" colspan="1">2.242</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1"><bold>Coronary artery disease</bold> (reference: without)</td><td rowspan="1" colspan="1">1.947</td><td rowspan="1" colspan="1">1.647</td><td rowspan="1" colspan="1">2.361</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">1.666</td><td rowspan="1" colspan="1">1.388</td><td rowspan="1" colspan="1">2.052</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1"><bold>Systemic lupus erythematosus</bold> (reference: without)</td><td rowspan="1" colspan="1">2.136</td><td rowspan="1" colspan="1">1.337</td><td rowspan="1" colspan="1">3.503</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">1.818</td><td rowspan="1" colspan="1">1.130</td><td rowspan="1" colspan="1">3.003</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1"><bold>Rheumatoid arthritis</bold> (reference: without)</td><td rowspan="1" colspan="1">2.562</td><td rowspan="1" colspan="1">1.263</td><td rowspan="1" colspan="1">5.336</td><td rowspan="1" colspan="1">0.007</td><td rowspan="1" colspan="1">2.975</td><td rowspan="1" colspan="1">1.459</td><td rowspan="1" colspan="1">6.231</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1"><bold>Deficiency anemias</bold> (reference: without)</td><td rowspan="1" colspan="1">1.714</td><td rowspan="1" colspan="1">1.242</td><td rowspan="1" colspan="1">2.427</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">2.389</td><td rowspan="1" colspan="1">1.721</td><td rowspan="1" colspan="1">3.406</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1"><bold>Fluid and electrolyte disorders</bold> (reference: without)</td><td rowspan="1" colspan="1">1.888</td><td rowspan="1" colspan="1">1.533</td><td rowspan="1" colspan="1">2.386</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">1.540</td><td rowspan="1" colspan="1">1.237</td><td rowspan="1" colspan="1">1.967</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1"><bold>Urbanization Level 1</bold> (reference: without)</td><td rowspan="1" colspan="1">0.783</td><td rowspan="1" colspan="1">0.814</td><td rowspan="1" colspan="1">1.027</td><td rowspan="1" colspan="1">0.068</td><td rowspan="1" colspan="1">0.833</td><td rowspan="1" colspan="1">0.690</td><td rowspan="1" colspan="1">1.032</td><td rowspan="1" colspan="1">0.073</td></tr><tr><td rowspan="1" colspan="1"><bold>Medical center</bold> (reference: without)</td><td rowspan="1" colspan="1">1.205</td><td rowspan="1" colspan="1">1.047</td><td rowspan="1" colspan="1">1.421</td><td rowspan="1" colspan="1">0.003</td><td rowspan="1" colspan="1">1.872</td><td rowspan="1" colspan="1">1.750</td><td rowspan="1" colspan="1">2.064</td><td rowspan="1" colspan="1">&lt;0.001</td></tr></tbody></table><table-wrap-foot><fn id="tfn0003"><p><bold>Abbreviations:</bold> SHR, subdistribution hazard ratio; CI, confidence interval; Adjusted HR, adjusted variables listed in the <xref rid="t0001" ref-type="table">Table 1</xref>.</p></fn></table-wrap-foot></table-wrap>
</p></sec><sec id="s0003-s2004"><title>Sensitivity Analysis and Types of Psychiatric Disorders After MS Diagnosis</title><p>As presented in <xref rid="t0003" ref-type="table">Table 3</xref>, the MS group had associations with psychiatric disorders such as depression, anxiety, bipolar disorder, sleep disorders, schizophrenia, schizophreniform disorder, and other psychotic disorder (adjusted HR: 12.464, 4.650, 6.987, 9.103, 2.552, 2.600, 2.441, and 2.574, respectively; all <italic toggle="yes">p</italic> &lt; 0.001) but not with substance-related disorders. The results of the sensitivity analysis of patients with MS (<xref rid="t0003" ref-type="table">Table 3</xref>) also indicated their association with an increased risk of psychiatric disorders such as depression, anxiety, bipolar disorder, sleep disorders, schizophrenia, schizophreniform disorder, and other psychotic disorder, even after the exclusion of patients who had been diagnosed these psychiatric disorders during the first 1 year. However, after exclusion of patients with these psychiatric disorders during the first 5 years, MS was not associated with schizophrenia and schizophreniform disorder.<table-wrap id="t0003" orientation="landscape" position="float"><label>Table 3</label><caption><p>Factors of Psychiatric Disorders Subgroup and Sensitivity Analysis by Using Fine and Gray&#8217;s Competing Risk Model</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" colspan="1">Sensitivity Analysis</th><th rowspan="1" colspan="1">MS (with vs without)</th><th rowspan="2" colspan="1">(N in the MS Patients)</th><th colspan="4" rowspan="1">No Competing Risk in the Model</th><th colspan="4" rowspan="1">Competing Risk in the Model</th></tr><tr><th rowspan="1" colspan="1">Psychiatric Diagnoses</th><th rowspan="1" colspan="1">Adjusted HR</th><th rowspan="1" colspan="1">95% CI</th><th rowspan="1" colspan="1">95% CI</th><th rowspan="1" colspan="1"><italic toggle="yes">P</italic></th><th rowspan="1" colspan="1">Adjusted SHR</th><th rowspan="1" colspan="1">95% CI</th><th rowspan="1" colspan="1">95% CI</th><th rowspan="1" colspan="1"><italic toggle="yes">P</italic></th></tr></thead><tbody><tr><td rowspan="1" colspan="1"><bold>Overall</bold></td><td rowspan="1" colspan="1"><bold>Overall</bold></td><td rowspan="1" colspan="1">531</td><td rowspan="1" colspan="1">5.063</td><td rowspan="1" colspan="1">4.447</td><td rowspan="1" colspan="1">5.870</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">5.044</td><td rowspan="1" colspan="1">4.448</td><td rowspan="1" colspan="1">5.870</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Depression</td><td rowspan="1" colspan="1">55</td><td rowspan="1" colspan="1">12.512</td><td rowspan="1" colspan="1">11.027</td><td rowspan="1" colspan="1">14.082</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">12.464</td><td rowspan="1" colspan="1">11.030</td><td rowspan="1" colspan="1">14.082</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Anxiety</td><td rowspan="1" colspan="1">447</td><td rowspan="1" colspan="1">4.668</td><td rowspan="1" colspan="1">4.114</td><td rowspan="1" colspan="1">5.254</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">4.650</td><td rowspan="1" colspan="1">4.115</td><td rowspan="1" colspan="1">5.254</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Bipolar</td><td rowspan="1" colspan="1">5</td><td rowspan="1" colspan="1">7.014</td><td rowspan="1" colspan="1">6.182</td><td rowspan="1" colspan="1">7.894</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">6.987</td><td rowspan="1" colspan="1">6.184</td><td rowspan="1" colspan="1">7.894</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Sleep disorders</td><td rowspan="1" colspan="1">38</td><td rowspan="1" colspan="1">9.139</td><td rowspan="1" colspan="1">8.054</td><td rowspan="1" colspan="1">10.285</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">9.103</td><td rowspan="1" colspan="1">8.056</td><td rowspan="1" colspan="1">10.285</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Psychotic disorders</td><td rowspan="1" colspan="1">7</td><td rowspan="1" colspan="1">2.562</td><td rowspan="1" colspan="1">2.258</td><td rowspan="1" colspan="1">2.883</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">2.552</td><td rowspan="1" colspan="1">2.258</td><td rowspan="1" colspan="1">2.883</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Schizophrenia</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">2.605</td><td rowspan="1" colspan="1">2.321</td><td rowspan="1" colspan="1">3.031</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">2.600</td><td rowspan="1" colspan="1">2.309</td><td rowspan="1" colspan="1">3.021</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Schizophreniform disorder</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">2.520</td><td rowspan="1" colspan="1">2.175</td><td rowspan="1" colspan="1">2.881</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">2.441</td><td rowspan="1" colspan="1">2.196</td><td rowspan="1" colspan="1">2.914</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Other psychotic disorders</td><td rowspan="1" colspan="1">4</td><td rowspan="1" colspan="1">2.588</td><td rowspan="1" colspan="1">2.285</td><td rowspan="1" colspan="1">3.008</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">2.574</td><td rowspan="1" colspan="1">2.270</td><td rowspan="1" colspan="1">3.003</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Substance-related disorders</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">0.580</td><td rowspan="1" colspan="1">0.331</td><td rowspan="1" colspan="1">1.676</td><td rowspan="1" colspan="1">0.278</td><td rowspan="1" colspan="1">0.578</td><td rowspan="1" colspan="1">0.365</td><td rowspan="1" colspan="1">1.679</td><td rowspan="1" colspan="1">0.306</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Alcohol use disorders</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">0.841</td><td rowspan="1" colspan="1">0.522</td><td rowspan="1" colspan="1">1.050</td><td rowspan="1" colspan="1">0.124</td><td rowspan="1" colspan="1">0.838</td><td rowspan="1" colspan="1">0.625</td><td rowspan="1" colspan="1">1.030</td><td rowspan="1" colspan="1">0.062</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Other drug use disorders</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">0.902</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">0.978</td></tr><tr><td rowspan="1" colspan="1"><bold>First year diagnoses excluded</bold></td><td rowspan="1" colspan="1"><bold>Overall</bold></td><td rowspan="1" colspan="1">269</td><td rowspan="1" colspan="1">3.334</td><td rowspan="1" colspan="1">2.927</td><td rowspan="1" colspan="1">3.865</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">3.320</td><td rowspan="1" colspan="1">2.928</td><td rowspan="1" colspan="1">3.865</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Depression</td><td rowspan="1" colspan="1">28</td><td rowspan="1" colspan="1">7.908</td><td rowspan="1" colspan="1">6.969</td><td rowspan="1" colspan="1">8.899</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">7.877</td><td rowspan="1" colspan="1">6.971</td><td rowspan="1" colspan="1">8.899</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Anxiety</td><td rowspan="1" colspan="1">228</td><td rowspan="1" colspan="1">3.099</td><td rowspan="1" colspan="1">2.730</td><td rowspan="1" colspan="1">3.487</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">3.086</td><td rowspan="1" colspan="1">2.731</td><td rowspan="1" colspan="1">3.487</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Bipolar</td><td rowspan="1" colspan="1">4</td><td rowspan="1" colspan="1">9.037</td><td rowspan="1" colspan="1">7.965</td><td rowspan="1" colspan="1">10.171</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">9.002</td><td rowspan="1" colspan="1">7.966</td><td rowspan="1" colspan="1">10.171</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Sleep disorders</td><td rowspan="1" colspan="1">17</td><td rowspan="1" colspan="1">4.955</td><td rowspan="1" colspan="1">4.367</td><td rowspan="1" colspan="1">5.578</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">4.936</td><td rowspan="1" colspan="1">4.368</td><td rowspan="1" colspan="1">5.578</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Psychotic disorders</td><td rowspan="1" colspan="1">5</td><td rowspan="1" colspan="1">2.259</td><td rowspan="1" colspan="1">1.991</td><td rowspan="1" colspan="1">2.542</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">2.250</td><td rowspan="1" colspan="1">1.991</td><td rowspan="1" colspan="1">2.542</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Schizophrenia</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">2.404</td><td rowspan="1" colspan="1">2.022</td><td rowspan="1" colspan="1">2.798</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">2.363</td><td rowspan="1" colspan="1">2.015</td><td rowspan="1" colspan="1">2.743</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Schizophreniform disorder</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">0.971</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">0.986</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Other psychotic disorders</td><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1">2.259</td><td rowspan="1" colspan="1">1.993</td><td rowspan="1" colspan="1">2.619</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">2.234</td><td rowspan="1" colspan="1">1.970</td><td rowspan="1" colspan="1">2.588</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Substance-related disorders</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">0.822</td><td rowspan="1" colspan="1">0.614</td><td rowspan="1" colspan="1">1.036</td><td rowspan="1" colspan="1">0.226</td><td rowspan="1" colspan="1">0.818</td><td rowspan="1" colspan="1">0.704</td><td rowspan="1" colspan="1">1.028</td><td rowspan="1" colspan="1">0.217</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Alcohol use disorders</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">1.130</td><td rowspan="1" colspan="1">0.995</td><td rowspan="1" colspan="1">1.272</td><td rowspan="1" colspan="1">0.238</td><td rowspan="1" colspan="1">1.125</td><td rowspan="1" colspan="1">0.996</td><td rowspan="1" colspan="1">1.273</td><td rowspan="1" colspan="1">0.279</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Other drug use disorders</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">0.897</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">0.942</td></tr><tr><td rowspan="1" colspan="1"><bold>First 5 years diagnoses excluded</bold></td><td rowspan="1" colspan="1"><bold>Overall</bold></td><td rowspan="1" colspan="1">62</td><td rowspan="1" colspan="1">2.792</td><td rowspan="1" colspan="1">2.451</td><td rowspan="1" colspan="1">3.236</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">2.780</td><td rowspan="1" colspan="1">2.452</td><td rowspan="1" colspan="1">3.236</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Depression</td><td rowspan="1" colspan="1">5</td><td rowspan="1" colspan="1">4.407</td><td rowspan="1" colspan="1">3.884</td><td rowspan="1" colspan="1">4.959</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">4.389</td><td rowspan="1" colspan="1">3.885</td><td rowspan="1" colspan="1">4.959</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Anxiety</td><td rowspan="1" colspan="1">50</td><td rowspan="1" colspan="1">2.442</td><td rowspan="1" colspan="1">2.152</td><td rowspan="1" colspan="1">2.748</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">2.432</td><td rowspan="1" colspan="1">2.153</td><td rowspan="1" colspan="1">2.748</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Bipolar</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">6.463</td><td rowspan="1" colspan="1">5.696</td><td rowspan="1" colspan="1">7.274</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">6.438</td><td rowspan="1" colspan="1">5.697</td><td rowspan="1" colspan="1">7.274</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Sleep disorders</td><td rowspan="1" colspan="1">6</td><td rowspan="1" colspan="1">5.288</td><td rowspan="1" colspan="1">4.660</td><td rowspan="1" colspan="1">5.951</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">5.268</td><td rowspan="1" colspan="1">4.661</td><td rowspan="1" colspan="1">5.951</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Psychotic disorders</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">1.763</td><td rowspan="1" colspan="1">1.553</td><td rowspan="1" colspan="1">1.983</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">1.756</td><td rowspan="1" colspan="1">1.554</td><td rowspan="1" colspan="1">1.983</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Schizophrenia</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">0.972</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">0.983</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Schizophreniform disorder</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">0.986</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">0.989</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Other psychotic disorders</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">1.756</td><td rowspan="1" colspan="1">1.505</td><td rowspan="1" colspan="1">2.062</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">1.727</td><td rowspan="1" colspan="1">1.435</td><td rowspan="1" colspan="1">2.000</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Substance-related disorders</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">0.796</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">0.763</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Alcohol use disorders</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">0.837</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">0.892</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Other drug use disorders</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">0.955</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">0.978</td></tr></tbody></table><table-wrap-foot><fn id="tfn0004"><p><bold>Abbreviations:</bold> PYs, person-years; SRD, substance-related disorders; HR, hazard ratio; SHR, subdistribution hazard ratio: adjusted for the variables listed in <xref rid="t0001" ref-type="table">Table 1</xref>; CI, confidence interval.</p></fn></table-wrap-foot></table-wrap>
</p></sec><sec id="s0003-s2005"><title>Medications for MS and the Risk of Psychiatric Disorders</title><p>We also analyzed the association between medications, or DMDs, for MS (<xref ref-type="fig" rid="f0003">Figure 3</xref>), and the portion of days covered (PDC) was 1%&#8211;50% (<xref rid="t0004" ref-type="table">Table 4</xref>). In general, the results revealed no association between the use of these medications and the overall risk of psychiatric disorders (<xref ref-type="fig" rid="f0004">Figure 4</xref> and <xref rid="t0005" ref-type="table">Table 5</xref>). However, in the present study, the use of glatiramer acetate, interferon-&#946;-1a, interferon-&#946;-1b, natalizumab, teriflunomide was determined to exhibit an association with a reduction in the anxiety risk. The use of glatiramer acetate, interferon-&#946;-1a, interferon-&#946;-1b, teriflunomide was also noted to exhibit an association with a reduction in the risk of depression.<table-wrap id="t0004" orientation="portrait" position="float"><label>Table 4</label><caption><p>Distribution of Disease-Modifying Medications for Multiple Sclerosis</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1">Variables</th><th rowspan="1" colspan="1">n</th><th rowspan="1" colspan="1">%</th><th rowspan="1" colspan="1">Events</th><th rowspan="1" colspan="1">Events %</th><th rowspan="1" colspan="1">PYs</th><th rowspan="1" colspan="1">Rate (per 10<sup>5</sup> PYs)</th></tr></thead><tbody><tr><td rowspan="1" colspan="1"><bold>Total</bold></td><td rowspan="1" colspan="1">1066</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">531</td><td rowspan="1" colspan="1">49.81</td><td rowspan="1" colspan="1">11,483.42</td><td rowspan="1" colspan="1">4624.06</td></tr><tr><td rowspan="1" colspan="1"><bold>Drugs</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;Without</td><td rowspan="1" colspan="1">882</td><td rowspan="1" colspan="1">82.74</td><td rowspan="1" colspan="1">456</td><td rowspan="1" colspan="1">51.70</td><td rowspan="1" colspan="1">9075.13</td><td rowspan="1" colspan="1">5024.72</td></tr><tr><td rowspan="1" colspan="1">&#8195;With</td><td rowspan="1" colspan="1">184</td><td rowspan="1" colspan="1">17.26</td><td rowspan="1" colspan="1">75</td><td rowspan="1" colspan="1">40.76</td><td rowspan="1" colspan="1">2408.29</td><td rowspan="1" colspan="1">3114.24</td></tr><tr><td rowspan="1" colspan="1"><bold>Fingolimod</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;Without</td><td rowspan="1" colspan="1">931</td><td rowspan="1" colspan="1">87.34</td><td rowspan="1" colspan="1">471</td><td rowspan="1" colspan="1">50.59</td><td rowspan="1" colspan="1">9739.24</td><td rowspan="1" colspan="1">4836.11</td></tr><tr><td rowspan="1" colspan="1">&#8195;PDC 1&#8211;50%</td><td rowspan="1" colspan="1">135</td><td rowspan="1" colspan="1">12.66</td><td rowspan="1" colspan="1">60</td><td rowspan="1" colspan="1">44.44</td><td rowspan="1" colspan="1">1744.18</td><td rowspan="1" colspan="1">3440.01</td></tr><tr><td rowspan="1" colspan="1">&#8195;PDC 51&#8211;100%</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">-</td></tr><tr><td rowspan="1" colspan="1">&#8195;MPR 1&#8211;50%</td><td rowspan="1" colspan="1">89</td><td rowspan="1" colspan="1">8.35</td><td rowspan="1" colspan="1">55</td><td rowspan="1" colspan="1">61.80</td><td rowspan="1" colspan="1">1216.99</td><td rowspan="1" colspan="1">4519.35</td></tr><tr><td rowspan="1" colspan="1">&#8195;MPR 51&#8211;100%</td><td rowspan="1" colspan="1">46</td><td rowspan="1" colspan="1">4.32</td><td rowspan="1" colspan="1">5</td><td rowspan="1" colspan="1">10.87</td><td rowspan="1" colspan="1">527.19</td><td rowspan="1" colspan="1">948.42</td></tr><tr><td rowspan="1" colspan="1"><bold>Glatiramer acetate</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;Without</td><td rowspan="1" colspan="1">929</td><td rowspan="1" colspan="1">87.15</td><td rowspan="1" colspan="1">474</td><td rowspan="1" colspan="1">51.02</td><td rowspan="1" colspan="1">9745.85</td><td rowspan="1" colspan="1">4863.61</td></tr><tr><td rowspan="1" colspan="1">&#8195;PDC 1&#8211;50%</td><td rowspan="1" colspan="1">137</td><td rowspan="1" colspan="1">12.85</td><td rowspan="1" colspan="1">57</td><td rowspan="1" colspan="1">41.61</td><td rowspan="1" colspan="1">1737.57</td><td rowspan="1" colspan="1">3280.44</td></tr><tr><td rowspan="1" colspan="1">&#8195;PDC 51&#8211;100%</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">-</td></tr><tr><td rowspan="1" colspan="1">&#8195;MPR 1&#8211;50%</td><td rowspan="1" colspan="1">97</td><td rowspan="1" colspan="1">9.10</td><td rowspan="1" colspan="1">51</td><td rowspan="1" colspan="1">52.58</td><td rowspan="1" colspan="1">1301.82</td><td rowspan="1" colspan="1">3917.59</td></tr><tr><td rowspan="1" colspan="1">&#8195;MPR 51&#8211;100%</td><td rowspan="1" colspan="1">40</td><td rowspan="1" colspan="1">3.75</td><td rowspan="1" colspan="1">6</td><td rowspan="1" colspan="1">15.00</td><td rowspan="1" colspan="1">435.75</td><td rowspan="1" colspan="1">1376.92</td></tr><tr><td rowspan="1" colspan="1"><bold>Interferon-&#946;-1a</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;Without</td><td rowspan="1" colspan="1">910</td><td rowspan="1" colspan="1">85.37</td><td rowspan="1" colspan="1">484</td><td rowspan="1" colspan="1">53.19</td><td rowspan="1" colspan="1">9645.12</td><td rowspan="1" colspan="1">5018.08</td></tr><tr><td rowspan="1" colspan="1">&#8195;PDC 1&#8211;50%</td><td rowspan="1" colspan="1">151</td><td rowspan="1" colspan="1">14.17</td><td rowspan="1" colspan="1">45</td><td rowspan="1" colspan="1">29.80</td><td rowspan="1" colspan="1">1533.25</td><td rowspan="1" colspan="1">2934.94</td></tr><tr><td rowspan="1" colspan="1">&#8195;PDC 51&#8211;100%</td><td rowspan="1" colspan="1">5</td><td rowspan="1" colspan="1">0.47</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">40.00</td><td rowspan="1" colspan="1">305.05</td><td rowspan="1" colspan="1">655.63</td></tr><tr><td rowspan="1" colspan="1">&#8195;MPR 1&#8211;50%</td><td rowspan="1" colspan="1">102</td><td rowspan="1" colspan="1">9.57</td><td rowspan="1" colspan="1">44</td><td rowspan="1" colspan="1">43.14</td><td rowspan="1" colspan="1">1425.25</td><td rowspan="1" colspan="1">3087.18</td></tr><tr><td rowspan="1" colspan="1">&#8195;MPR 51&#8211;100%</td><td rowspan="1" colspan="1">54</td><td rowspan="1" colspan="1">5.07</td><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1">5.56</td><td rowspan="1" colspan="1">413.05</td><td rowspan="1" colspan="1">726.30</td></tr><tr><td rowspan="1" colspan="1"><bold>Interferon-&#946;-1b</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;Without</td><td rowspan="1" colspan="1">918</td><td rowspan="1" colspan="1">86.12</td><td rowspan="1" colspan="1">501</td><td rowspan="1" colspan="1">54.58</td><td rowspan="1" colspan="1">9575.98</td><td rowspan="1" colspan="1">5231.84</td></tr><tr><td rowspan="1" colspan="1">&#8195;PDC 1&#8211;50%</td><td rowspan="1" colspan="1">142</td><td rowspan="1" colspan="1">13.32</td><td rowspan="1" colspan="1">29</td><td rowspan="1" colspan="1">20.42</td><td rowspan="1" colspan="1">1513.12</td><td rowspan="1" colspan="1">1916.57</td></tr><tr><td rowspan="1" colspan="1">&#8195;PDC 51&#8211;100%</td><td rowspan="1" colspan="1">6</td><td rowspan="1" colspan="1">0.56</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">16.67</td><td rowspan="1" colspan="1">394.32</td><td rowspan="1" colspan="1">253.60</td></tr><tr><td rowspan="1" colspan="1">&#8195;MPR 1&#8211;50%</td><td rowspan="1" colspan="1">101</td><td rowspan="1" colspan="1">9.47</td><td rowspan="1" colspan="1">28</td><td rowspan="1" colspan="1">27.72</td><td rowspan="1" colspan="1">1499.76</td><td rowspan="1" colspan="1">1866.97</td></tr><tr><td rowspan="1" colspan="1">&#8195;MPR 51&#8211;100%</td><td rowspan="1" colspan="1">47</td><td rowspan="1" colspan="1">4.41</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">4.26</td><td rowspan="1" colspan="1">407.68</td><td rowspan="1" colspan="1">490.58</td></tr><tr><td rowspan="1" colspan="1"><bold>Natalizumab</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;Without</td><td rowspan="1" colspan="1">924</td><td rowspan="1" colspan="1">86.68</td><td rowspan="1" colspan="1">510</td><td rowspan="1" colspan="1">55.19</td><td rowspan="1" colspan="1">9480.25</td><td rowspan="1" colspan="1">5379.60</td></tr><tr><td rowspan="1" colspan="1">&#8195;PDC 1&#8211;50%</td><td rowspan="1" colspan="1">131</td><td rowspan="1" colspan="1">12.29</td><td rowspan="1" colspan="1">20</td><td rowspan="1" colspan="1">15.27</td><td rowspan="1" colspan="1">1813.12</td><td rowspan="1" colspan="1">1103.07</td></tr><tr><td rowspan="1" colspan="1">&#8195;PDC 51&#8211;100%</td><td rowspan="1" colspan="1">11</td><td rowspan="1" colspan="1">1.03</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">9.09</td><td rowspan="1" colspan="1">190.05</td><td rowspan="1" colspan="1">526.18</td></tr><tr><td rowspan="1" colspan="1">&#8195;MPR 1&#8211;50%</td><td rowspan="1" colspan="1">94</td><td rowspan="1" colspan="1">8.82</td><td rowspan="1" colspan="1">20</td><td rowspan="1" colspan="1">21.28</td><td rowspan="1" colspan="1">1806.27</td><td rowspan="1" colspan="1">1107.25</td></tr><tr><td rowspan="1" colspan="1">&#8195;MPR 51&#8211;100%</td><td rowspan="1" colspan="1">48</td><td rowspan="1" colspan="1">4.50</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">2.08</td><td rowspan="1" colspan="1">196.90</td><td rowspan="1" colspan="1">507.87</td></tr><tr><td rowspan="1" colspan="1"><bold>Teriflunomide</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;Without</td><td rowspan="1" colspan="1">928</td><td rowspan="1" colspan="1">87.05</td><td rowspan="1" colspan="1">498</td><td rowspan="1" colspan="1">53.66</td><td rowspan="1" colspan="1">9698.25</td><td rowspan="1" colspan="1">5134.95</td></tr><tr><td rowspan="1" colspan="1">&#8195;PDC 1&#8211;50%</td><td rowspan="1" colspan="1">130</td><td rowspan="1" colspan="1">12.20</td><td rowspan="1" colspan="1">33</td><td rowspan="1" colspan="1">25.38</td><td rowspan="1" colspan="1">1327.42</td><td rowspan="1" colspan="1">2486.03</td></tr><tr><td rowspan="1" colspan="1">&#8195;PDC 51&#8211;100%</td><td rowspan="1" colspan="1">8</td><td rowspan="1" colspan="1">0.75</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">457.75</td><td rowspan="1" colspan="1">0</td></tr><tr><td rowspan="1" colspan="1">&#8195;MPR 1&#8211;50%</td><td rowspan="1" colspan="1">107</td><td rowspan="1" colspan="1">10.04</td><td rowspan="1" colspan="1">29</td><td rowspan="1" colspan="1">27.10</td><td rowspan="1" colspan="1">1301.56</td><td rowspan="1" colspan="1">2228.10</td></tr><tr><td rowspan="1" colspan="1">&#8195;MPR 51&#8211;100%</td><td rowspan="1" colspan="1">31</td><td rowspan="1" colspan="1">2.91</td><td rowspan="1" colspan="1">4</td><td rowspan="1" colspan="1">12.90</td><td rowspan="1" colspan="1">483.61</td><td rowspan="1" colspan="1">827.11</td></tr></tbody></table><table-wrap-foot><fn id="tfn0005"><p><bold>Abbreviations:</bold> PYs, Person-year; PDC, portion of days covered; MPR, medication possession ratio.</p></fn></table-wrap-foot></table-wrap>
<table-wrap id="t0005" orientation="landscape" position="float"><label>Table 5</label><caption><p>Factors of Subgroup in Different Disease-Modifying Drugs Among Multiple Sclerosis Patients by Using Cox Regression and Fine and Gray&#8217;s Competing Risk Model</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" colspan="1">Drugs (Reference: without)</th><th rowspan="1" colspan="1">Model</th><th colspan="4" rowspan="1">No Competing Risk in the Model</th><th colspan="4" rowspan="1">Competing Risk in the Model</th></tr><tr><th rowspan="1" colspan="1">Dementia Subgroup</th><th rowspan="1" colspan="1">Adjusted HR</th><th rowspan="1" colspan="1">95% CI</th><th rowspan="1" colspan="1">95% CI</th><th rowspan="1" colspan="1"><italic toggle="yes">P</italic></th><th rowspan="1" colspan="1">Adjusted SHR</th><th rowspan="1" colspan="1">95% CI</th><th rowspan="1" colspan="1">95% CI</th><th rowspan="1" colspan="1"><italic toggle="yes">P</italic></th></tr></thead><tbody><tr><td rowspan="1" colspan="1"><bold>Overall</bold></td><td rowspan="1" colspan="1"><bold>Overall</bold></td><td rowspan="1" colspan="1">0.666</td><td rowspan="1" colspan="1">0.423</td><td rowspan="1" colspan="1">1.075</td><td rowspan="1" colspan="1">0.401</td><td rowspan="1" colspan="1">0.670</td><td rowspan="1" colspan="1">0.418</td><td rowspan="1" colspan="1">1.086</td><td rowspan="1" colspan="1">0.375</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Depression</td><td rowspan="1" colspan="1">0.572</td><td rowspan="1" colspan="1">0.222</td><td rowspan="1" colspan="1">1.267</td><td rowspan="1" colspan="1">0.133</td><td rowspan="1" colspan="1">0.522</td><td rowspan="1" colspan="1">0.223</td><td rowspan="1" colspan="1">1.210</td><td rowspan="1" colspan="1">0.134</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Anxiety</td><td rowspan="1" colspan="1">0.731</td><td rowspan="1" colspan="1">0.512</td><td rowspan="1" colspan="1">0.963</td><td rowspan="1" colspan="1">0.023</td><td rowspan="1" colspan="1">0.744</td><td rowspan="1" colspan="1">0.572</td><td rowspan="1" colspan="1">0.969</td><td rowspan="1" colspan="1">0.029</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Bipolar</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">0.866</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">0.945</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Sleep disorders</td><td rowspan="1" colspan="1">0.501</td><td rowspan="1" colspan="1">0.178</td><td rowspan="1" colspan="1">1.413</td><td rowspan="1" colspan="1">0.203</td><td rowspan="1" colspan="1">0.586</td><td rowspan="1" colspan="1">0.284</td><td rowspan="1" colspan="1">1.563</td><td rowspan="1" colspan="1">0.242</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Psychotic disorders</td><td rowspan="1" colspan="1">1.563</td><td rowspan="1" colspan="1">0.303</td><td rowspan="1" colspan="1">7.986</td><td rowspan="1" colspan="1">0.672</td><td rowspan="1" colspan="1">1.489</td><td rowspan="1" colspan="1">0.301</td><td rowspan="1" colspan="1">7.761</td><td rowspan="1" colspan="1">0.668</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Schizophrenia</td><td rowspan="1" colspan="1">1.298</td><td rowspan="1" colspan="1">0.212</td><td rowspan="1" colspan="1">7.425</td><td rowspan="1" colspan="1">0.663</td><td rowspan="1" colspan="1">1.283</td><td rowspan="1" colspan="1">0.205</td><td rowspan="1" colspan="1">7.413</td><td rowspan="1" colspan="1">0.651</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Schizophreniform disorder</td><td rowspan="1" colspan="1">1.387</td><td rowspan="1" colspan="1">0.298</td><td rowspan="1" colspan="1">7.774</td><td rowspan="1" colspan="1">0.670</td><td rowspan="1" colspan="1">1.375</td><td rowspan="1" colspan="1">0.287</td><td rowspan="1" colspan="1">7.758</td><td rowspan="1" colspan="1">0.665</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Other psychotic disorders</td><td rowspan="1" colspan="1">1.675</td><td rowspan="1" colspan="1">0.426</td><td rowspan="1" colspan="1">8.030</td><td rowspan="1" colspan="1">0.684</td><td rowspan="1" colspan="1">1.652</td><td rowspan="1" colspan="1">0.411</td><td rowspan="1" colspan="1">7.992</td><td rowspan="1" colspan="1">0.681</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Substance-related disorders</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">0.632</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">0.671</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Alcohol use disorders</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">0.611</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">0.662</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Other substance use disorders</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">0.995</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">0.998</td></tr><tr><td rowspan="1" colspan="1"><bold>Fingolimod</bold></td><td rowspan="1" colspan="1"><bold>Overall</bold></td><td rowspan="1" colspan="1">0.741</td><td rowspan="1" colspan="1">0.568</td><td rowspan="1" colspan="1">1.176</td><td rowspan="1" colspan="1">0.355</td><td rowspan="1" colspan="1">0.743</td><td rowspan="1" colspan="1">0.569</td><td rowspan="1" colspan="1">1.182</td><td rowspan="1" colspan="1">0.377</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Depression</td><td rowspan="1" colspan="1">0.588</td><td rowspan="1" colspan="1">0.235</td><td rowspan="1" colspan="1">1.478</td><td rowspan="1" colspan="1">0.267</td><td rowspan="1" colspan="1">0.592</td><td rowspan="1" colspan="1">0.236</td><td rowspan="1" colspan="1">1.487</td><td rowspan="1" colspan="1">0.273</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Anxiety</td><td rowspan="1" colspan="1">0.768</td><td rowspan="1" colspan="1">0.574</td><td rowspan="1" colspan="1">1.026</td><td rowspan="1" colspan="1">0.089</td><td rowspan="1" colspan="1">0.789</td><td rowspan="1" colspan="1">0.575</td><td rowspan="1" colspan="1">1.027</td><td rowspan="1" colspan="1">0.091</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Bipolar</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">0.517</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">0.565</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Sleep disorders</td><td rowspan="1" colspan="1">0.689</td><td rowspan="1" colspan="1">0.244</td><td rowspan="1" colspan="1">1.945</td><td rowspan="1" colspan="1">0.491</td><td rowspan="1" colspan="1">0.694</td><td rowspan="1" colspan="1">0.246</td><td rowspan="1" colspan="1">1.958</td><td rowspan="1" colspan="1">0.498</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Psychotic disorders</td><td rowspan="1" colspan="1">2.188</td><td rowspan="1" colspan="1">0.422</td><td rowspan="1" colspan="1">11.346</td><td rowspan="1" colspan="1">0.339</td><td rowspan="1" colspan="1">2.219</td><td rowspan="1" colspan="1">0.428</td><td rowspan="1" colspan="1">11.504</td><td rowspan="1" colspan="1">0.331</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Schizophrenia</td><td rowspan="1" colspan="1">2.065</td><td rowspan="1" colspan="1">0.386</td><td rowspan="1" colspan="1">9.865</td><td rowspan="1" colspan="1">0.277</td><td rowspan="1" colspan="1">2.097</td><td rowspan="1" colspan="1">0.397</td><td rowspan="1" colspan="1">10.120</td><td rowspan="1" colspan="1">0.284</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Schizophreniform disorder</td><td rowspan="1" colspan="1">2.131</td><td rowspan="1" colspan="1">0.403</td><td rowspan="1" colspan="1">10.331</td><td rowspan="1" colspan="1">0.320</td><td rowspan="1" colspan="1">2.178</td><td rowspan="1" colspan="1">0.421</td><td rowspan="1" colspan="1">10.867</td><td rowspan="1" colspan="1">0.328</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Other psychotic disorders</td><td rowspan="1" colspan="1">2.244</td><td rowspan="1" colspan="1">0.482</td><td rowspan="1" colspan="1">11.429</td><td rowspan="1" colspan="1">0.384</td><td rowspan="1" colspan="1">2.299</td><td rowspan="1" colspan="1">0.503</td><td rowspan="1" colspan="1">11.682</td><td rowspan="1" colspan="1">0.396</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Substance-related disorders</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">0.693</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">0.761</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Alcohol use disorders</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">0.692</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">0.760</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Other substance use disorders</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">0.976</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">0.978</td></tr><tr><td rowspan="1" colspan="1"><bold>Glatiramer acetate</bold></td><td rowspan="1" colspan="1"><bold>Overall</bold></td><td rowspan="1" colspan="1">0.629</td><td rowspan="1" colspan="1">0.457</td><td rowspan="1" colspan="1">1.172</td><td rowspan="1" colspan="1">0.138</td><td rowspan="1" colspan="1">0.695</td><td rowspan="1" colspan="1">0.317</td><td rowspan="1" colspan="1">1.584</td><td rowspan="1" colspan="1">0.380</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Depression</td><td rowspan="1" colspan="1">0.470</td><td rowspan="1" colspan="1">0.170</td><td rowspan="1" colspan="1">1.301</td><td rowspan="1" colspan="1">0.151</td><td rowspan="1" colspan="1">0.473</td><td rowspan="1" colspan="1">0.171</td><td rowspan="1" colspan="1">1.310</td><td rowspan="1" colspan="1">0.155</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Anxiety</td><td rowspan="1" colspan="1">0.784</td><td rowspan="1" colspan="1">0.586</td><td rowspan="1" colspan="1">0.969</td><td rowspan="1" colspan="1">0.038</td><td rowspan="1" colspan="1">0.785</td><td rowspan="1" colspan="1">0.587</td><td rowspan="1" colspan="1">0.973</td><td rowspan="1" colspan="1">0.041</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Bipolar</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">0.351</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">0.367</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Sleep disorders</td><td rowspan="1" colspan="1">0.518</td><td rowspan="1" colspan="1">0.159</td><td rowspan="1" colspan="1">1.689</td><td rowspan="1" colspan="1">0.281</td><td rowspan="1" colspan="1">0.522</td><td rowspan="1" colspan="1">0.161</td><td rowspan="1" colspan="1">1.702</td><td rowspan="1" colspan="1">0.287</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Psychotic disorders</td><td rowspan="1" colspan="1">2.405</td><td rowspan="1" colspan="1">0.466</td><td rowspan="1" colspan="1">12.421</td><td rowspan="1" colspan="1">0.284</td><td rowspan="1" colspan="1">2.441</td><td rowspan="1" colspan="1">0.473</td><td rowspan="1" colspan="1">12.610</td><td rowspan="1" colspan="1">0.276</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Schizophrenia</td><td rowspan="1" colspan="1">2.321</td><td rowspan="1" colspan="1">0.401</td><td rowspan="1" colspan="1">11.785</td><td rowspan="1" colspan="1">0.226</td><td rowspan="1" colspan="1">2.386</td><td rowspan="1" colspan="1">0.431</td><td rowspan="1" colspan="1">11.976</td><td rowspan="1" colspan="1">0.204</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Schizophreniform disorder</td><td rowspan="1" colspan="1">2.385</td><td rowspan="1" colspan="1">0.457</td><td rowspan="1" colspan="1">12.011</td><td rowspan="1" colspan="1">0.271</td><td rowspan="1" colspan="1">2.404</td><td rowspan="1" colspan="1">0.462</td><td rowspan="1" colspan="1">12.448</td><td rowspan="1" colspan="1">0.258</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Other psychotic disorders</td><td rowspan="1" colspan="1">2.434</td><td rowspan="1" colspan="1">0.513</td><td rowspan="1" colspan="1">12.986</td><td rowspan="1" colspan="1">0.375</td><td rowspan="1" colspan="1">2.473</td><td rowspan="1" colspan="1">0.589</td><td rowspan="1" colspan="1">13.375</td><td rowspan="1" colspan="1">0.317</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Substance-related disorders</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">0.842</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">0.853</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Alcohol use disorders</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">0.838</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">0.849</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Other substance use disorders</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">0.959</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">0.975</td></tr><tr><td rowspan="1" colspan="1"><bold>Interferon-&#946;-1a</bold></td><td rowspan="1" colspan="1"><bold>Overall</bold></td><td rowspan="1" colspan="1">0.683</td><td rowspan="1" colspan="1">0.229</td><td rowspan="1" colspan="1">1.321</td><td rowspan="1" colspan="1">0.258</td><td rowspan="1" colspan="1">0.688</td><td rowspan="1" colspan="1">0.251</td><td rowspan="1" colspan="1">1.980</td><td rowspan="1" colspan="1">0.204</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Depression</td><td rowspan="1" colspan="1">0.611</td><td rowspan="1" colspan="1">0.353</td><td rowspan="1" colspan="1">0.978</td><td rowspan="1" colspan="1">0.027</td><td rowspan="1" colspan="1">0.603</td><td rowspan="1" colspan="1">0.270</td><td rowspan="1" colspan="1">0.907</td><td rowspan="1" colspan="1">0.002</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Anxiety</td><td rowspan="1" colspan="1">0.562</td><td rowspan="1" colspan="1">0.305</td><td rowspan="1" colspan="1">0.921</td><td rowspan="1" colspan="1">0.003</td><td rowspan="1" colspan="1">0.552</td><td rowspan="1" colspan="1">0.286</td><td rowspan="1" colspan="1">0.911</td><td rowspan="1" colspan="1">0.001</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Bipolar</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">0.898</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">0.912</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Sleep disorders</td><td rowspan="1" colspan="1">0.702</td><td rowspan="1" colspan="1">0.465</td><td rowspan="1" colspan="1">1.986</td><td rowspan="1" colspan="1">0.702</td><td rowspan="1" colspan="1">0.729</td><td rowspan="1" colspan="1">0.503</td><td rowspan="1" colspan="1">2.234</td><td rowspan="1" colspan="1">0.698</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Psychotic disorders</td><td rowspan="1" colspan="1">1.025</td><td rowspan="1" colspan="1">0.331</td><td rowspan="1" colspan="1">1.865</td><td rowspan="1" colspan="1">0.612</td><td rowspan="1" colspan="1">1.123</td><td rowspan="1" colspan="1">0.465</td><td rowspan="1" colspan="1">2.131</td><td rowspan="1" colspan="1">0.603</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Schizophrenia</td><td rowspan="1" colspan="1">0.986</td><td rowspan="1" colspan="1">0.246</td><td rowspan="1" colspan="1">1.683</td><td rowspan="1" colspan="1">0.505</td><td rowspan="1" colspan="1">0.994</td><td rowspan="1" colspan="1">0.371</td><td rowspan="1" colspan="1">1.705</td><td rowspan="1" colspan="1">0.503</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Schizophreniform disorder</td><td rowspan="1" colspan="1">1.011</td><td rowspan="1" colspan="1">0.287</td><td rowspan="1" colspan="1">1.774</td><td rowspan="1" colspan="1">0.572</td><td rowspan="1" colspan="1">1.086</td><td rowspan="1" colspan="1">0.442</td><td rowspan="1" colspan="1">1.972</td><td rowspan="1" colspan="1">0.555</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Other psychotic disorders</td><td rowspan="1" colspan="1">1.027</td><td rowspan="1" colspan="1">0.352</td><td rowspan="1" colspan="1">1.895</td><td rowspan="1" colspan="1">0.638</td><td rowspan="1" colspan="1">1.197</td><td rowspan="1" colspan="1">0.586</td><td rowspan="1" colspan="1">2.186</td><td rowspan="1" colspan="1">0.611</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Substance-related disorders</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">0.862</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">0.912</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Alcohol use disorders</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">0.976</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">0.986</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Other substance use disorders</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">0.933</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">0.975</td></tr><tr><td rowspan="1" colspan="1"><bold>Interferon-&#946;-1b</bold></td><td rowspan="1" colspan="1"><bold>Overall</bold></td><td rowspan="1" colspan="1">0.785</td><td rowspan="1" colspan="1">0.422</td><td rowspan="1" colspan="1">1.256</td><td rowspan="1" colspan="1">0.223</td><td rowspan="1" colspan="1">0.794</td><td rowspan="1" colspan="1">0.483</td><td rowspan="1" colspan="1">1.367</td><td rowspan="1" colspan="1">0.254</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Depression</td><td rowspan="1" colspan="1">0.533</td><td rowspan="1" colspan="1">0.372</td><td rowspan="1" colspan="1">0.986</td><td rowspan="1" colspan="1">0.039</td><td rowspan="1" colspan="1">0.552</td><td rowspan="1" colspan="1">0.384</td><td rowspan="1" colspan="1">0.952</td><td rowspan="1" colspan="1">0.022</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Anxiety</td><td rowspan="1" colspan="1">0.482</td><td rowspan="1" colspan="1">0.306</td><td rowspan="1" colspan="1">0.925</td><td rowspan="1" colspan="1">0.010</td><td rowspan="1" colspan="1">0.497</td><td rowspan="1" colspan="1">0.311</td><td rowspan="1" colspan="1">0.914</td><td rowspan="1" colspan="1">0.004</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Bipolar</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">0.897</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">0.903</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Sleep disorders</td><td rowspan="1" colspan="1">0.862</td><td rowspan="1" colspan="1">0.562</td><td rowspan="1" colspan="1">1.287</td><td rowspan="1" colspan="1">0.796</td><td rowspan="1" colspan="1">0.972</td><td rowspan="1" colspan="1">0.672</td><td rowspan="1" colspan="1">1.597</td><td rowspan="1" colspan="1">0.711</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Psychotic disorders</td><td rowspan="1" colspan="1">0.994</td><td rowspan="1" colspan="1">0.765</td><td rowspan="1" colspan="1">1.306</td><td rowspan="1" colspan="1">0.535</td><td rowspan="1" colspan="1">1.204</td><td rowspan="1" colspan="1">0.886</td><td rowspan="1" colspan="1">2.013</td><td rowspan="1" colspan="1">0.672</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Schizophrenia</td><td rowspan="1" colspan="1">0.952</td><td rowspan="1" colspan="1">0.542</td><td rowspan="1" colspan="1">1.184</td><td rowspan="1" colspan="1">0.502</td><td rowspan="1" colspan="1">0.996</td><td rowspan="1" colspan="1">0.556</td><td rowspan="1" colspan="1">1.487</td><td rowspan="1" colspan="1">0.611</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Schizophreniform disorder</td><td rowspan="1" colspan="1">1.097</td><td rowspan="1" colspan="1">0.688</td><td rowspan="1" colspan="1">1.211</td><td rowspan="1" colspan="1">0.530</td><td rowspan="1" colspan="1">1.125</td><td rowspan="1" colspan="1">0.701</td><td rowspan="1" colspan="1">1.706</td><td rowspan="1" colspan="1">0.653</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Other psychotic disorders</td><td rowspan="1" colspan="1">1.246</td><td rowspan="1" colspan="1">0.803</td><td rowspan="1" colspan="1">1.562</td><td rowspan="1" colspan="1">0.569</td><td rowspan="1" colspan="1">1.284</td><td rowspan="1" colspan="1">0.897</td><td rowspan="1" colspan="1">2.025</td><td rowspan="1" colspan="1">0.684</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Substance-related disorders</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">0.896</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">0.903</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Alcohol use disorders</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">0.883</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">0.903</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Other substance use disorders</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">0.964</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">0.972</td></tr><tr><td rowspan="1" colspan="1"><bold>Natalizumab</bold></td><td rowspan="1" colspan="1"><bold>Overall</bold></td><td rowspan="1" colspan="1">0.714</td><td rowspan="1" colspan="1">0.553</td><td rowspan="1" colspan="1">1.066</td><td rowspan="1" colspan="1">0.424</td><td rowspan="1" colspan="1">0.728</td><td rowspan="1" colspan="1">0.569</td><td rowspan="1" colspan="1">1.078</td><td rowspan="1" colspan="1">0.463</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Depression</td><td rowspan="1" colspan="1">0.884</td><td rowspan="1" colspan="1">0.672</td><td rowspan="1" colspan="1">1.030</td><td rowspan="1" colspan="1">0.089</td><td rowspan="1" colspan="1">0.897</td><td rowspan="1" colspan="1">0.688</td><td rowspan="1" colspan="1">1.124</td><td rowspan="1" colspan="1">0.131</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Anxiety</td><td rowspan="1" colspan="1">0.702</td><td rowspan="1" colspan="1">0.511</td><td rowspan="1" colspan="1">0.962</td><td rowspan="1" colspan="1">0.024</td><td rowspan="1" colspan="1">0.713</td><td rowspan="1" colspan="1">0.534</td><td rowspan="1" colspan="1">0.986</td><td rowspan="1" colspan="1">0.033</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Bipolar</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">0.712</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">0.865</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Sleep disorders</td><td rowspan="1" colspan="1">0.803</td><td rowspan="1" colspan="1">0.598</td><td rowspan="1" colspan="1">1.724</td><td rowspan="1" colspan="1">0.386</td><td rowspan="1" colspan="1">0.834</td><td rowspan="1" colspan="1">0.661</td><td rowspan="1" colspan="1">2.561</td><td rowspan="1" colspan="1">0.399</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Psychotic disorders</td><td rowspan="1" colspan="1">1.030</td><td rowspan="1" colspan="1">0.666</td><td rowspan="1" colspan="1">1.802</td><td rowspan="1" colspan="1">0.295</td><td rowspan="1" colspan="1">1.135</td><td rowspan="1" colspan="1">0.689</td><td rowspan="1" colspan="1">2.978</td><td rowspan="1" colspan="1">0.304</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Schizophrenia</td><td rowspan="1" colspan="1">0.892</td><td rowspan="1" colspan="1">0.601</td><td rowspan="1" colspan="1">1.713</td><td rowspan="1" colspan="1">0.276</td><td rowspan="1" colspan="1">0.972</td><td rowspan="1" colspan="1">0.638</td><td rowspan="1" colspan="1">2.886</td><td rowspan="1" colspan="1">0.285</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Schizophreniform disorder</td><td rowspan="1" colspan="1">1.045</td><td rowspan="1" colspan="1">0.782</td><td rowspan="1" colspan="1">2.035</td><td rowspan="1" colspan="1">0.308</td><td rowspan="1" colspan="1">1.206</td><td rowspan="1" colspan="1">0.833</td><td rowspan="1" colspan="1">3.015</td><td rowspan="1" colspan="1">0.311</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Other psychotic disorders</td><td rowspan="1" colspan="1">0.997</td><td rowspan="1" colspan="1">0.643</td><td rowspan="1" colspan="1">1.786</td><td rowspan="1" colspan="1">0.281</td><td rowspan="1" colspan="1">1.085</td><td rowspan="1" colspan="1">0.672</td><td rowspan="1" colspan="1">2.956</td><td rowspan="1" colspan="1">0.297</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Substance-related disorders</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">0.974</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">0.985</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Alcohol use disorders</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">0.986</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">0.977</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Other substance use disorders</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">0.913</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">0.973</td></tr><tr><td rowspan="1" colspan="1"><bold>Teriflunomide</bold></td><td rowspan="1" colspan="1"><bold>Overall</bold></td><td rowspan="1" colspan="1">0.825</td><td rowspan="1" colspan="1">0.398</td><td rowspan="1" colspan="1">2.896</td><td rowspan="1" colspan="1">0.483</td><td rowspan="1" colspan="1">0.899</td><td rowspan="1" colspan="1">0.412</td><td rowspan="1" colspan="1">3.011</td><td rowspan="1" colspan="1">0.499</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Depression</td><td rowspan="1" colspan="1">0.664</td><td rowspan="1" colspan="1">0.402</td><td rowspan="1" colspan="1">0.936</td><td rowspan="1" colspan="1">0.011</td><td rowspan="1" colspan="1">0.688</td><td rowspan="1" colspan="1">0.435</td><td rowspan="1" colspan="1">0.972</td><td rowspan="1" colspan="1">0.028</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Anxiety</td><td rowspan="1" colspan="1">0.502</td><td rowspan="1" colspan="1">0.345</td><td rowspan="1" colspan="1">0.892</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">0.598</td><td rowspan="1" colspan="1">0.387</td><td rowspan="1" colspan="1">0.902</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Bipolar</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">0.901</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">0.925</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Sleep disorders</td><td rowspan="1" colspan="1">0.975</td><td rowspan="1" colspan="1">0.251</td><td rowspan="1" colspan="1">4.980</td><td rowspan="1" colspan="1">0.702</td><td rowspan="1" colspan="1">1.007</td><td rowspan="1" colspan="1">0.356</td><td rowspan="1" colspan="1">5.131</td><td rowspan="1" colspan="1">0.687</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Psychotic disorders</td><td rowspan="1" colspan="1">1.137</td><td rowspan="1" colspan="1">0.336</td><td rowspan="1" colspan="1">5.582</td><td rowspan="1" colspan="1">0.684</td><td rowspan="1" colspan="1">1.397</td><td rowspan="1" colspan="1">0.403</td><td rowspan="1" colspan="1">6.254</td><td rowspan="1" colspan="1">0.703</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Schizophrenia</td><td rowspan="1" colspan="1">1.206</td><td rowspan="1" colspan="1">0.453</td><td rowspan="1" colspan="1">5.986</td><td rowspan="1" colspan="1">0.633</td><td rowspan="1" colspan="1">1.452</td><td rowspan="1" colspan="1">0.657</td><td rowspan="1" colspan="1">6.842</td><td rowspan="1" colspan="1">0.650</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Schizophreniform disorder</td><td rowspan="1" colspan="1">1.085</td><td rowspan="1" colspan="1">0.303</td><td rowspan="1" colspan="1">5.010</td><td rowspan="1" colspan="1">0.695</td><td rowspan="1" colspan="1">1.186</td><td rowspan="1" colspan="1">0.338</td><td rowspan="1" colspan="1">5.687</td><td rowspan="1" colspan="1">0.717</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Other psychotic disorders</td><td rowspan="1" colspan="1">1.114</td><td rowspan="1" colspan="1">0.324</td><td rowspan="1" colspan="1">5.443</td><td rowspan="1" colspan="1">0.672</td><td rowspan="1" colspan="1">1.370</td><td rowspan="1" colspan="1">0.392</td><td rowspan="1" colspan="1">6.011</td><td rowspan="1" colspan="1">0.684</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Substance-related disorders</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">0.868</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">0.918</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Alcohol use disorders</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">0.899</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">0.903</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Other substance use disorders</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">0.951</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">0.942</td></tr></tbody></table><table-wrap-foot><fn id="tfn0006"><p><bold>Abbreviations:</bold> PYs, person-years; SHR, subdistribution Hazard ratio: adjusted for the variables listed in <xref rid="t0001" ref-type="table">Table 1</xref>; CI, confidence interval.</p></fn></table-wrap-foot></table-wrap>
<fig id="f0003" fig-type="figure" orientation="portrait" position="float"><label>Figure 3</label><caption><p>The flowchart of study sample selection from National Health Insurance Research Database in Taiwan.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" content-type="print-only" position="float" orientation="portrait" xlink:href="NDT-17-587-g0003.jpg"/></fig><fig id="f0004" fig-type="figure" orientation="portrait" position="float"><label>Figure 4</label><caption><p>Kaplan&#8211;Meier for cumulative risk of psychiatric disorders among MS patients aged 20 and over stratified by treatment with Log rank test.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" content-type="print-only" position="float" orientation="portrait" xlink:href="NDT-17-587-g0004.jpg"/></fig></p></sec></sec><sec id="s0004"><title>Discussion</title><sec id="s0004-s2001"><title>Association Between MS, DMDs, and the Risk of Psychiatric Disorders</title><p>Our derived results suggest that MS is associated with an elevated risk of psychiatric disorders among adults. We also noted that after covariates were adjusted for, the risk of psychiatric disorders is nearly five-fold greater among adults with MS relative to those without MS. The results of Kaplan&#8211;Meier analysis indicated that the patients with MS in this study had a significantly higher rate of survival for 15 years without psychiatric disorders than did adults without MS.</p><p>In addition, we found that the DMD compliance among patients with MS was lower than 50% because the PDC was 1%&#8211;50%. Although some studies conducted in other countries have addressed this matter, the present study is also the first to report findings regarding DMD adherence or compliance in Taiwan.<xref rid="cit0061" ref-type="bibr">61</xref>,<xref rid="cit0062" ref-type="bibr">62</xref> Furthermore, the use of such DMDs was noted to exhibit an association with a reduction in the anxiety and depression risks.</p></sec><sec id="s0004-s2002"><title>Comparison of This Study with Previous Literature</title><p>A previously executed systematic review ranked psychiatric disorders as follows with respect to their prevalence: depression (23.7%), anxiety (21.9%), alcohol abuse (14.8%), bipolar disorder (5.83%), psychosis (4.3%), and substance abuse (2.5%).<xref rid="cit0020" ref-type="bibr">20</xref> Compared with the population-based studies on individual disorders, such as anxiety disorders,<xref rid="cit0021" ref-type="bibr">21</xref>,<xref rid="cit0063" ref-type="bibr">63</xref>,<xref rid="cit0064" ref-type="bibr">64</xref> depression,<xref rid="cit0064" ref-type="bibr">64</xref>,<xref rid="cit0065" ref-type="bibr">65</xref> and psychosis,<xref rid="cit0024" ref-type="bibr">24</xref> identified during our systematic review, our study is the first to use a large and nationwide administrative data set for several major psychiatric disorders.</p><p>Furthermore, the treatment prevalence rates of the psychiatric disorders among the patients in our study were 83.9% for anxiety disorders, 10.3% for depression, and 7.1% for sleep disorders; by contrast, the prevalence rates of psychotic disorders, bipolar disorder, and substance-related disorders were lower than 2% in the reviewed studies.<xref rid="cit0014" ref-type="bibr">14</xref> We speculate that this difference may be related to the different follow-up period and different enrollment criteria for psychiatric disorders in this study. This study enrolled only patients who had made three visits in a year for treating their diagnosed psychiatric disorder. Furthermore, our study involved a longer follow-up duration for the psychiatric disorders in the patients with MS following their hospital stay; this longer duration constitutes a strength of the study. However, the reasons for this difference require further investigation.</p><p>Confavreux and Compston reported that the prognosis for men with MS is typically worse than that for women, and disability appears to have more of an impact on the quality of life in men.<xref rid="cit0066" ref-type="bibr">66</xref> Another study also found that the very early stages of MS are accompanied by disturbances in psychological well-being and mild cognitive dysfunction, particularly in male patients.<xref rid="cit0067" ref-type="bibr">67</xref> However, in the present study, male patients with MS were determined to have a lower risk of psychiatric disorders (adjusted HR = 0.792 [95% CI = 0.651&#8211;0.953, <italic toggle="yes">p</italic> = 0.006]). One possible explanation for this finding is that the psychological support provided by the health professionals might be insufficient for men,<xref rid="cit0068" ref-type="bibr">68</xref> thus reducing the rates of early detection and early referrals and consequently lowering the psychiatric diagnostic rates in the NHIRD. Furthermore, previous studies have found that the male patients generally tended to be reluctant to seek help from psychiatric services.<xref rid="cit0069" ref-type="bibr">69&#8211;71</xref> This might also contribute to the apparently lower risk of psychiatric disorders in the male patients with MS. In addition, we determined higher insurance premiums to have an association with a higher MS risk. The reasons underlying this association are not known. We speculate that subjects with higher insurance premiums, suggesting that they have higher income, might have higher accessibility to health care systems. Nonetheless, the reasons for this lower risk are still unknown and need to be researched further with more detail.</p><p>In contrast to other studies, although this study found an association between MS and an increased risk of anxiety, depression, psychotic disorders, sleep disorders, and bipolar disorder, no association was noted between MS and substance-related disorders.<xref rid="cit0072" ref-type="bibr">72</xref>,<xref rid="cit0073" ref-type="bibr">73</xref> Low baseline rates of alcohol or drug use disorders in Taiwan might be one explanation for this discrepancy.<xref rid="cit0074" ref-type="bibr">74</xref></p><p>In this claims data set&#8211;based study, we identified patients with MS on the basis of a discharge diagnosis of MS, as confirmed by CIC approval. The number of patients with MS who did not have CICs was difficult to estimate because all studies on the prevalence of MS in Taiwan have analyzed data from the NHIRD.<xref rid="cit0015" ref-type="bibr">15&#8211;17</xref>,<xref rid="cit0075" ref-type="bibr">75</xref> However, we speculate that most of the patients with MS were issued CICs because NHI regulations exempt them from copayment for MS&#8208;related medical care. Furthermore, most researchers using data from the NHIRD have used CIC status to confirm MS diagnosis.<xref rid="cit0024" ref-type="bibr">24</xref>,<xref rid="cit0025" ref-type="bibr">25</xref>,<xref rid="cit0046" ref-type="bibr">46</xref>,<xref rid="cit0056" ref-type="bibr">56</xref>,<xref rid="cit0076" ref-type="bibr">76&#8211;81</xref> Nonetheless, a community-based study in Taiwan is necessary to determine the proportion of patients with MS who do not have CICs. In addition, NHI regulations mandate that a period of three to seven days elapse after confirmation of diagnosis by a physician before CICs can be issued so that medical charts can be reviewed by NHIA-appointed specialists to verify the validity of certificates issued for CIC-qualifiable diseases, including MS.<xref rid="cit0082" ref-type="bibr">82</xref> However, determining the mean number of days between diagnosis of MS and CIC registration remains difficult.</p></sec><sec id="s0004-s2003"><title>Potential Mechanisms Underlying the Elevated Risk of Psychiatric Disorders Among Patients with MS</title><p>Studies have reported associations of multiple factors, such as brain pathology, genetics, immunological changes, psychosocial influences, and dysregulation of the hypothalamic&#8211;pituitary&#8211;adrenal axis, with anxiety disorders and depression.<xref rid="cit0083" ref-type="bibr">83</xref> One study reported that MS, depressive disorder, bipolar disorder, and schizophrenia may share the mechanism of downregulating oligodendrocyte genes.<xref rid="cit0084" ref-type="bibr">84</xref> However, the mechanisms that underlie the MS&#8211;psychiatric disorder risk association require further investigation.</p></sec><sec id="s0004-s2004"><title>Study Strengths</title><p>This research has certain strengths. First, we employed Taiwan&#8217;s NHIRD, a very important resource covering a nationwide population. Second, other studies have verified the diagnostic validity of several neuropsychiatric disorders included in the NHIRD, including Tourette syndrome,<xref rid="cit0085" ref-type="bibr">85</xref> stroke,<xref rid="cit0086" ref-type="bibr">86&#8211;89</xref> sleep apnea,<xref rid="cit0090" ref-type="bibr">90</xref> and major depressive disorder.<xref rid="cit0091" ref-type="bibr">91</xref> Moreover, as mentioned, in-hospital licensed medical record technicians and NHI administrators would have verified the diagnoses in the claims data set.<xref rid="cit0027" ref-type="bibr">27</xref>,<xref rid="cit0044" ref-type="bibr">44</xref> Third, the consistency between the NHIRD and Taiwan&#8217;s National Health Survey with respect to various diagnoses,<xref rid="cit0092" ref-type="bibr">92</xref> medication usages,<xref rid="cit0092" ref-type="bibr">92</xref> and health system utilizations<xref rid="cit0092" ref-type="bibr">92</xref>,<xref rid="cit0093" ref-type="bibr">93</xref> has been verified by research. Fourth, a benefit of the Fine and Gray model is that it includes real mortality data for investigating how MS influences the risk of psychiatric disorders.<xref rid="cit0094" ref-type="bibr">94</xref>,<xref rid="cit0095" ref-type="bibr">95</xref> Therefore, this study was conducted using a large, nationwide, and reliable database to determine the association between MS and psychiatric morbidities in an Asian country.</p></sec><sec id="s0004-s2005"><title>Limitations of This Study</title><p>This research has a few limitations that should be considered. First, because not all pieces of data are recorded in the NHIRD, we could not evaluate the influence of family history, neurological severity, types, laboratory parameters, findings from additional examinations (eg, neuroimaging), or use of rehabilitation services.<xref rid="cit0080" ref-type="bibr">80</xref> Therefore, the lack of data regarding the clinical and radiological course and treatment of the disease is a limitation of this nationwide study with a large sample size, similar to the case for other studies that have used the NHIRD to investigate MS.<xref rid="cit0024" ref-type="bibr">24</xref>,<xref rid="cit0056" ref-type="bibr">56</xref>,<xref rid="cit0076" ref-type="bibr">76</xref>,<xref rid="cit0077" ref-type="bibr">77</xref> Second, data regarding certain factors, such as those related to environmental conditions, psychosocial characteristics, and genetics, were not part of the data set. Because the data we applied in our study spanned 15 years and encompassed the entirety of the hospitals in Taiwan and more than 99% of Taiwan&#8217;s population, they are likely to be representative and valid.</p></sec></sec><sec id="s0005"><title>Conclusions</title><p>The present study provides evidence demonstrating that MS is associated with an increase in the risk of psychiatric disorders, such as anxiety disorders, depression, and bipolar disorder. This finding can remind clinicians regarding the importance of considering the risk of psychiatric disorders subsequently arising among patients with MS. For example, clinicians could use the mental health screening instruments to identify the patients at risk early on. Additional studies are warranted to explore the association of MS with depression and anxiety disorders in a larger community sample by setting a longer follow-up duration and considering lifestyle, family history, psychosocial stressors, and MS severity.</p></sec></body><back><ack><title>Acknowledgments</title><p>This work was supported by the Medical Affairs Bureau, the Ministry of Defense of Taiwan (MND-MAB-107-084 and MND-MAB-110-087), and the Tri-Service General Hospital Research Foundation (TSGH-C108-003, TSGHC108-027, TSGH-C108-151, TSGH-E-110240, TSGH-B-109-010, and TSGH-B-110012). These funding agencies did not influence the study design, data collection and analysis, decision to publish, or preparation of the manuscript. We also appreciate Taiwan&#8217;s Health and Welfare Data Science Center and the Ministry of Health and Welfare (HWDC, MOHW) for providing the National Health Research Database.</p></ack><sec id="s0006"><title>Data Sharing Statement</title><p>Data are available from the NHIRD published by the Taiwan NHI administration. Because of legal restrictions imposed by the government of Taiwan concerning the &#8220;Personal Information Protection Act,&#8221; data cannot be made publicly available. Requests for data can be sent as a formal proposal to the NHIRD (<underline><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.mohw.gov.tw/cht/DOS/DM1.aspx?f_list_no=812">http://www.mohw.gov.tw/cht/DOS/DM1.aspx?f_list_no=812</ext-link></underline>).</p></sec><sec id="s0007"><title>Author Contributions</title><p>All authors made substantial contributions to the conception and design, acquisition of data, or analysis and interpretation of data; took part in drafting the article or revising it critically for important intellectual content; have approved of the final version of the manuscript for publication; and agree to be accountable for all aspects of the work.</p></sec><sec id="s0008" sec-type="COI-statement"><title>Disclosure</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec><ref-list><title>References</title><ref id="cit0001"><label>1.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Thompson</surname><given-names>AJ</given-names></string-name>, <string-name name-style="western"><surname>Baranzini</surname><given-names>SE</given-names></string-name>, <string-name name-style="western"><surname>Geurts</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Hemmer</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Ciccarelli</surname><given-names>O</given-names></string-name>. <article-title>Multiple sclerosis</article-title>. <source><italic toggle="yes">Lancet</italic></source>. <year>2018</year>;<volume>391</volume>(<issue>10130</issue>):<fpage>1622</fpage>&#8211;<lpage>1636</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0140-6736(18)30481-1</pub-id><pub-id pub-id-type="pmid">29576504</pub-id></mixed-citation></ref><ref id="cit0002"><label>2.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Moore</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Vickrey</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Fortin</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Lee</surname><given-names>L</given-names></string-name>. <article-title>Two multiple sclerosis quality-of-life measures: comparison in a national sample</article-title>. <source><italic toggle="yes">Can J Neurol Sci</italic></source>. <year>2015</year>;<volume>42</volume>(<issue>1</issue>):<fpage>55</fpage>&#8211;<lpage>63</lpage>. doi:<pub-id pub-id-type="doi">10.1017/cjn.2014.128</pub-id><pub-id pub-id-type="pmid">25586701</pub-id></mixed-citation></ref><ref id="cit0003"><label>3.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Filippi</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Preziosa</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Rocca</surname><given-names>MA</given-names></string-name>. <article-title>Brain mapping in multiple sclerosis: lessons learned about the human brain</article-title>. <source><italic toggle="yes">NeuroImage</italic></source>. <year>2017</year>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.neuroimage.2017.09.021</pub-id><pub-id pub-id-type="pmid">28917696</pub-id></mixed-citation></ref><ref id="cit0004"><label>4.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Marrie</surname><given-names>RA</given-names></string-name>, <string-name name-style="western"><surname>Walld</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Bolton</surname><given-names>JM</given-names></string-name>, et al. <article-title>Increased incidence of psychiatric disorders in immune-mediated inflammatory disease</article-title>. <source><italic toggle="yes">J Psychosom Res</italic></source>. <year>2017</year>;<volume>101</volume>:<fpage>17</fpage>&#8211;<lpage>23</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jpsychores.2017.07.015</pub-id><pub-id pub-id-type="pmid">28867419</pub-id></mixed-citation></ref><ref id="cit0005"><label>5.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Tzeng</surname><given-names>NS</given-names></string-name>, <string-name name-style="western"><surname>Chang</surname><given-names>HA</given-names></string-name>, <string-name name-style="western"><surname>Chung</surname><given-names>CH</given-names></string-name>, et al. <article-title>Risk of psychiatric disorders in Guillain-Barre syndrome: a nationwide, population-based, cohort study</article-title>. <source><italic toggle="yes">J Neurol Sci</italic></source>. <year>2017</year>;<volume>381</volume>:<fpage>88</fpage>&#8211;<lpage>94</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jns.2017.08.022</pub-id><pub-id pub-id-type="pmid">28991722</pub-id></mixed-citation></ref><ref id="cit0006"><label>6.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Tzeng</surname><given-names>NS</given-names></string-name>, <string-name name-style="western"><surname>Chung</surname><given-names>CH</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>FC</given-names></string-name>, et al. <article-title>Fibromyalgia and risk of dementia-A Nationwide, Population-Based, Cohort Study</article-title>. <source><italic toggle="yes">Am J Med Sci</italic></source>. <year>2018</year>;<volume>355</volume>(<issue>2</issue>):<fpage>153</fpage>&#8211;<lpage>161</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.amjms.2017.09.002</pub-id><pub-id pub-id-type="pmid">29406043</pub-id></mixed-citation></ref><ref id="cit0007"><label>7.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Tzeng</surname><given-names>NS</given-names></string-name>, <string-name name-style="western"><surname>Chang</surname><given-names>HA</given-names></string-name>, <string-name name-style="western"><surname>Chung</surname><given-names>CH</given-names></string-name>, et al. <article-title>Increased risk of psychiatric disorders in allergic diseases: a Nationwide, Population-Based, Cohort Study</article-title>. <source><italic toggle="yes">Front Psychiatry</italic></source>. <year>2018</year>;<volume>9</volume>:<fpage>133</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fpsyt.2018.00133</pub-id><pub-id pub-id-type="pmid">29740354</pub-id><pub-id pub-id-type="pmcid">PMC5928780</pub-id></mixed-citation></ref><ref id="cit0008"><label>8.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Tzeng</surname><given-names>NS</given-names></string-name>, <string-name name-style="western"><surname>Chung</surname><given-names>CH</given-names></string-name>, <string-name name-style="western"><surname>Yeh</surname><given-names>CB</given-names></string-name>, et al. <article-title>Are chronic periodontitis and gingivitis associated with dementia? A Nationwide, Retrospective, Matched-Cohort Study in Taiwan</article-title>. <source><italic toggle="yes">Neuroepidemiology</italic></source>. <year>2016</year>;<volume>47</volume>(<issue>2</issue>):<fpage>82</fpage>&#8211;<lpage>93</lpage>. doi:<pub-id pub-id-type="doi">10.1159/000449166</pub-id><pub-id pub-id-type="pmid">27618156</pub-id></mixed-citation></ref><ref id="cit0009"><label>9.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Chen</surname><given-names>CK</given-names></string-name>, <string-name name-style="western"><surname>Wu</surname><given-names>YT</given-names></string-name>, <string-name name-style="western"><surname>Chang</surname><given-names>YC</given-names></string-name>. <article-title>Association between chronic periodontitis and the risk of Alzheimer&#8217;s disease: a retrospective, population-based, matched-cohort study</article-title>. <source><italic toggle="yes">Alzheimer&#8217;s Res Ther</italic></source>. <year>2017</year>;<volume>9</volume>(<issue>1</issue>):<fpage>56</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s13195-017-0282-6</pub-id><pub-id pub-id-type="pmid">28784164</pub-id><pub-id pub-id-type="pmcid">PMC5547465</pub-id></mixed-citation></ref><ref id="cit0010"><label>10.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Lee</surname><given-names>YL</given-names></string-name>, <string-name name-style="western"><surname>Hu</surname><given-names>HY</given-names></string-name>, <string-name name-style="western"><surname>Huang</surname><given-names>LY</given-names></string-name>, <string-name name-style="western"><surname>Chou</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Chu</surname><given-names>D</given-names></string-name>. <article-title>Periodontal disease associated with higher risk of dementia: population-Based Cohort Study in Taiwan</article-title>. <source><italic toggle="yes">J Am Geriatr Soc</italic></source>. <year>2017</year>;<volume>65</volume>(<issue>9</issue>):<fpage>1975</fpage>&#8211;<lpage>1980</lpage>. doi:<pub-id pub-id-type="doi">10.1111/jgs.14944</pub-id><pub-id pub-id-type="pmid">28598507</pub-id></mixed-citation></ref><ref id="cit0011"><label>11.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Lee</surname><given-names>YT</given-names></string-name>, <string-name name-style="western"><surname>Lee</surname><given-names>HC</given-names></string-name>, <string-name name-style="western"><surname>Hu</surname><given-names>CJ</given-names></string-name>, et al. <article-title>Periodontitis as a Modifiable risk factor for dementia: a Nationwide Population-Based Cohort Study</article-title>. <source><italic toggle="yes">J Am Geriatr Soc</italic></source>. <year>2017</year>;<volume>65</volume>(<issue>2</issue>):<fpage>301</fpage>&#8211;<lpage>305</lpage>. doi:<pub-id pub-id-type="doi">10.1111/jgs.14449</pub-id><pub-id pub-id-type="pmid">27685603</pub-id></mixed-citation></ref><ref id="cit0012"><label>12.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Sgambato</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Miranda</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Ranaldo</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Federico</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Romano</surname><given-names>M</given-names></string-name>. <article-title>The role of stress in inflammatory bowel diseases</article-title>. <source><italic toggle="yes">Curr Pharm Des</italic></source>. <year>2017</year>;<volume>23</volume>(<issue>27</issue>). doi:<pub-id pub-id-type="doi">10.2174/1381612823666170228123357</pub-id><pub-id pub-id-type="pmid">28245757</pub-id></mixed-citation></ref><ref id="cit0013"><label>13.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Marrie</surname><given-names>RA</given-names></string-name>, <string-name name-style="western"><surname>Reingold</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Cohen</surname><given-names>J</given-names></string-name>, et al. <article-title>The incidence and prevalence of psychiatric disorders in multiple sclerosis: a systematic review</article-title>. <source><italic toggle="yes">Mult Scler J</italic></source>. <year>2015</year>;<volume>21</volume>(<issue>3</issue>):<fpage>305</fpage>&#8211;<lpage>317</lpage>. doi:<pub-id pub-id-type="doi">10.1177/1352458514564487</pub-id><pub-id pub-id-type="pmcid">PMC4429164</pub-id><pub-id pub-id-type="pmid">25583845</pub-id></mixed-citation></ref><ref id="cit0014"><label>14.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Marrie</surname><given-names>RA</given-names></string-name>, <string-name name-style="western"><surname>Reider</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Cohen</surname><given-names>J</given-names></string-name>, et al. <article-title>A systematic review of the incidence and prevalence of sleep disorders and seizure disorders in multiple sclerosis</article-title>. <source><italic toggle="yes">Mult Scler J</italic></source>. <year>2015</year>;<volume>21</volume>(<issue>3</issue>):<fpage>342</fpage>&#8211;<lpage>349</lpage>. doi:<pub-id pub-id-type="doi">10.1177/1352458514564486</pub-id><pub-id pub-id-type="pmcid">PMC4429167</pub-id><pub-id pub-id-type="pmid">25533301</pub-id></mixed-citation></ref><ref id="cit0015"><label>15.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Tsai</surname><given-names>CP</given-names></string-name>, <string-name name-style="western"><surname>Yuan</surname><given-names>CL</given-names></string-name>, <string-name name-style="western"><surname>Yu</surname><given-names>HY</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Guo</surname><given-names>YC</given-names></string-name>, <string-name name-style="western"><surname>Shan</surname><given-names>DE</given-names></string-name>. <article-title>Multiple sclerosis in Taiwan</article-title>. <source><italic toggle="yes">J Chin Med Assoc</italic></source>. <year>2004</year>;<volume>67</volume>(<issue>10</issue>):<fpage>500</fpage>&#8211;<lpage>505</lpage>.<pub-id pub-id-type="pmid">15648284</pub-id></mixed-citation></ref><ref id="cit0016"><label>16.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Lai</surname><given-names>CH</given-names></string-name>, <string-name name-style="western"><surname>Tseng</surname><given-names>HF</given-names></string-name>. <article-title>Population-based epidemiological study of neurological diseases in Taiwan: I. Creutzfeldt-Jakob disease and multiple sclerosis</article-title>. <source><italic toggle="yes">Neuroepidemiology</italic></source>. <year>2009</year>;<volume>33</volume>(<issue>3</issue>):<fpage>247</fpage>&#8211;<lpage>253</lpage>. doi:<pub-id pub-id-type="doi">10.1159/000229779</pub-id><pub-id pub-id-type="pmid">19641330</pub-id></mixed-citation></ref><ref id="cit0017"><label>17.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Cheong</surname><given-names>WL</given-names></string-name>, <string-name name-style="western"><surname>Mohan</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Warren</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Reidpath</surname><given-names>DD</given-names></string-name>. <article-title>Multiple sclerosis in the Asia Pacific region: a systematic review of a neglected neurological disease</article-title>. <source><italic toggle="yes">Front Neurol</italic></source>. <year>2018</year>;<volume>9</volume>:<fpage>432</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fneur.2018.00432</pub-id><pub-id pub-id-type="pmid">29937752</pub-id><pub-id pub-id-type="pmcid">PMC6002494</pub-id></mixed-citation></ref><ref id="cit0018"><label>18.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Wallin</surname><given-names>MT</given-names></string-name>, <string-name name-style="western"><surname>Culpepper</surname><given-names>WJ</given-names></string-name>, <string-name name-style="western"><surname>Campbell</surname><given-names>JD</given-names></string-name>, et al. <article-title>The prevalence of MS in the United States: A population-based estimate using health claims data</article-title>. <source><italic toggle="yes">Neurology</italic></source>. <year>2019</year>;<volume>92</volume>(<issue>10</issue>):<fpage>e1029</fpage>&#8211;<lpage>e1040</lpage>. doi:<pub-id pub-id-type="doi">10.1212/WNL.0000000000007035</pub-id><pub-id pub-id-type="pmid">30770430</pub-id><pub-id pub-id-type="pmcid">PMC6442006</pub-id></mixed-citation></ref><ref id="cit0019"><label>19.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Dilokthornsakul</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Valuck</surname><given-names>RJ</given-names></string-name>, <string-name name-style="western"><surname>Nair</surname><given-names>KV</given-names></string-name>, <string-name name-style="western"><surname>Corboy</surname><given-names>JR</given-names></string-name>, <string-name name-style="western"><surname>Allen</surname><given-names>RR</given-names></string-name>, <string-name name-style="western"><surname>Campbell</surname><given-names>JD</given-names></string-name>. <article-title>Multiple sclerosis prevalence in the United States commercially insured population</article-title>. <source><italic toggle="yes">Neurology</italic></source>. <year>2016</year>;<volume>86</volume>(<issue>11</issue>):<fpage>1014</fpage>&#8211;<lpage>1021</lpage>. doi:<pub-id pub-id-type="doi">10.1212/WNL.0000000000002469</pub-id><pub-id pub-id-type="pmid">26888980</pub-id><pub-id pub-id-type="pmcid">PMC4799713</pub-id></mixed-citation></ref><ref id="cit0020"><label>20.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Marrie</surname><given-names>RA</given-names></string-name>, <string-name name-style="western"><surname>Cohen</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Stuve</surname><given-names>O</given-names></string-name>, et al. <article-title>A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: overview</article-title>. <source><italic toggle="yes">Mult Scler J</italic></source>. <year>2015</year>;<volume>21</volume>(<issue>3</issue>):<fpage>263</fpage>&#8211;<lpage>281</lpage>. doi:<pub-id pub-id-type="doi">10.1177/1352458514564491</pub-id><pub-id pub-id-type="pmcid">PMC4361468</pub-id><pub-id pub-id-type="pmid">25623244</pub-id></mixed-citation></ref><ref id="cit0021"><label>21.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Marrie</surname><given-names>RA</given-names></string-name>, <string-name name-style="western"><surname>Fisk</surname><given-names>JD</given-names></string-name>, <string-name name-style="western"><surname>Yu</surname><given-names>BN</given-names></string-name>, et al. <article-title>Mental comorbidity and multiple sclerosis: validating administrative data to support population-based surveillance</article-title>. <source><italic toggle="yes">BMC Neurol</italic></source>. <year>2013</year>;<volume>13</volume>:<fpage>16</fpage>. doi:<pub-id pub-id-type="doi">10.1186/1471-2377-13-16</pub-id><pub-id pub-id-type="pmid">23388102</pub-id><pub-id pub-id-type="pmcid">PMC3599013</pub-id></mixed-citation></ref><ref id="cit0022"><label>22.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Marrie</surname><given-names>RA</given-names></string-name>, <string-name name-style="western"><surname>Miller</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Sormani</surname><given-names>MP</given-names></string-name>, et al. <article-title>Recommendations for observational studies of comorbidity in multiple sclerosis</article-title>. <source><italic toggle="yes">Neurology</italic></source>. <year>2016</year>;<volume>86</volume>(<issue>15</issue>):<fpage>1446</fpage>&#8211;<lpage>1453</lpage>. doi:<pub-id pub-id-type="doi">10.1212/WNL.0000000000002474</pub-id><pub-id pub-id-type="pmid">26865523</pub-id><pub-id pub-id-type="pmcid">PMC4831039</pub-id></mixed-citation></ref><ref id="cit0023"><label>23.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Marrie</surname><given-names>RA</given-names></string-name>, <string-name name-style="western"><surname>Walld</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Bolton</surname><given-names>JM</given-names></string-name>, et al. <article-title>Rising incidence of psychiatric disorders before diagnosis of immune-mediated inflammatory disease</article-title>. <source><italic toggle="yes">Epidemiol Psychiatr Sci</italic></source>. <year>2017</year>;<volume>1&#8211;10</volume>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1017/S2045796017000579</pub-id><pub-id pub-id-type="pmcid">PMC6998907</pub-id><pub-id pub-id-type="pmid">29098977</pub-id></mixed-citation></ref><ref id="cit0024"><label>24.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Kang</surname><given-names>JH</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>YH</given-names></string-name>, <string-name name-style="western"><surname>Lin</surname><given-names>HC</given-names></string-name>. <article-title>Comorbidities amongst patients with multiple sclerosis: a population-based controlled study</article-title>. <source><italic toggle="yes">Eur J Neurol</italic></source>. <year>2010</year>;<volume>17</volume>(<issue>9</issue>):<fpage>1215</fpage>&#8211;<lpage>1219</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1468-1331.2010.02971.x</pub-id><pub-id pub-id-type="pmid">20192982</pub-id></mixed-citation></ref><ref id="cit0025"><label>25.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Keller</surname><given-names>JJ</given-names></string-name>, <string-name name-style="western"><surname>Liang</surname><given-names>YC</given-names></string-name>, <string-name name-style="western"><surname>Lin</surname><given-names>HC</given-names></string-name>. <article-title>Association between multiple sclerosis and erectile dysfunction: a nationwide case-control study</article-title>. <source><italic toggle="yes">J Sex Med</italic></source>. <year>2012</year>;<volume>9</volume>(<issue>7</issue>):<fpage>1753</fpage>&#8211;<lpage>1759</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1743-6109.2012.02746.x</pub-id><pub-id pub-id-type="pmid">22548978</pub-id></mixed-citation></ref><ref id="cit0026"><label>26.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Ho Chan</surname><given-names>WS</given-names></string-name>. <article-title>Taiwan&#8217;s healthcare report 2010</article-title>. <source><italic toggle="yes">EPMA J</italic></source>. <year>2010</year>;<volume>1</volume>(<issue>4</issue>):<fpage>563</fpage>&#8211;<lpage>585</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s13167-010-0056-8</pub-id><pub-id pub-id-type="pmid">23199110</pub-id><pub-id pub-id-type="pmcid">PMC3405348</pub-id></mixed-citation></ref><ref id="cit0027"><label>27.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Hsieh</surname><given-names>C-Y</given-names></string-name>, <string-name name-style="western"><surname>Su</surname><given-names>-C-C</given-names></string-name>, <string-name name-style="western"><surname>Shao</surname><given-names>S-C</given-names></string-name>, et al. <article-title>Taiwan&#8217;s National Health Insurance Research Database: past and future</article-title>. <source><italic toggle="yes">Clin Epidemiol</italic></source>. <year>2019</year>;<volume>11</volume>:<fpage>349</fpage>&#8211;<lpage>358</lpage>. doi:<pub-id pub-id-type="doi">10.2147/CLEP.S196293</pub-id><pub-id pub-id-type="pmid">31118821</pub-id><pub-id pub-id-type="pmcid">PMC6509937</pub-id></mixed-citation></ref><ref id="cit0028"><label>28.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Chien</surname><given-names>WC</given-names></string-name>, <string-name name-style="western"><surname>Chung</surname><given-names>CH</given-names></string-name>, <string-name name-style="western"><surname>Lin</surname><given-names>FH</given-names></string-name>, <string-name name-style="western"><surname>Chang</surname><given-names>HA</given-names></string-name>, <string-name name-style="western"><surname>Kao</surname><given-names>YC</given-names></string-name>, <string-name name-style="western"><surname>Tzeng</surname><given-names>NS</given-names></string-name>. <article-title>Is weight control surgery associated with increased risk of newly onset psychiatric disorders? A population-based, matched cohort study in Taiwan</article-title>. <source><italic toggle="yes">J Med Sci</italic></source>. <year>2017</year>;<volume>37</volume>(<issue>4</issue>):<fpage>137</fpage>&#8211;<lpage>149</lpage>. doi:<pub-id pub-id-type="doi">10.4103/jmedsci.jmedsci_94_16</pub-id></mixed-citation></ref><ref id="cit0029"><label>29.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Kao</surname><given-names>LC</given-names></string-name>, <string-name name-style="western"><surname>Chien</surname><given-names>WC</given-names></string-name>, <string-name name-style="western"><surname>Chung</surname><given-names>CH</given-names></string-name>, et al. <article-title>The newly diagnosed amnestic disorders and dementia: a Nationwide, Cohort Study in Taiwan</article-title>. <source><italic toggle="yes">Taiwan J Psychiatry</italic></source>. <year>2018</year>;<volume>32</volume>(<issue>1</issue>):<fpage>18</fpage>&#8211;<lpage>28</lpage>.</mixed-citation></ref><ref id="cit0030"><label>30.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Yang</surname><given-names>CC</given-names></string-name>, <string-name name-style="western"><surname>Chien</surname><given-names>WC</given-names></string-name>, <string-name name-style="western"><surname>Chung</surname><given-names>CH</given-names></string-name>, et al. <article-title>No association between human immunodeficiency virus infections and dementia: a Nationwide Cohort Study In Taiwan</article-title>. <source><italic toggle="yes">Neuropsychiatr Dis Treat</italic></source>. <year>2019</year>;<volume>15</volume>:<fpage>3155</fpage>&#8211;<lpage>3166</lpage>. doi:<pub-id pub-id-type="doi">10.2147/NDT.S225584</pub-id><pub-id pub-id-type="pmid">31814723</pub-id><pub-id pub-id-type="pmcid">PMC6863184</pub-id></mixed-citation></ref><ref id="cit0031"><label>31.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Chen</surname><given-names>TY</given-names></string-name>, <string-name name-style="western"><surname>Huang</surname><given-names>CH</given-names></string-name>, <string-name name-style="western"><surname>Chung</surname><given-names>CH</given-names></string-name>, et al. <article-title>Sex and age differences in the association between anxiety disorders and narcolepsy: A nationwide population-based case control study</article-title>. <source><italic toggle="yes">J Affect Disord</italic></source>. <year>2020</year>;<volume>264</volume>:<fpage>130</fpage>&#8211;<lpage>137</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jad.2019.12.010</pub-id><pub-id pub-id-type="pmid">32056742</pub-id></mixed-citation></ref><ref id="cit0032"><label>32.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Lin</surname><given-names>YC</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>TY</given-names></string-name>, <string-name name-style="western"><surname>Chien</surname><given-names>WC</given-names></string-name>, et al. <article-title>Stimulants associated with reduced risk of hospitalization for motor vehicle accident injury in patients with obstructive sleep apnea-a nationwide cohort study</article-title>. <source><italic toggle="yes">BMC Pulm Med</italic></source>. <year>2020</year>;<volume>20</volume>(<issue>1</issue>). doi:<pub-id pub-id-type="doi">10.1186/s12890-019-1041-1</pub-id>.<pub-id pub-id-type="pmcid">PMC6998364</pub-id><pub-id pub-id-type="pmid">32013932</pub-id></mixed-citation></ref><ref id="cit0033"><label>33.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Liu</surname><given-names>YP</given-names></string-name>, <string-name name-style="western"><surname>Chien</surname><given-names>WC</given-names></string-name>, <string-name name-style="western"><surname>Chung</surname><given-names>CH</given-names></string-name>, <string-name name-style="western"><surname>Chang</surname><given-names>HA</given-names></string-name>, <string-name name-style="western"><surname>Kao</surname><given-names>YC</given-names></string-name>, <string-name name-style="western"><surname>Tzeng</surname><given-names>NS</given-names></string-name>. <article-title>Are anticholinergic medications associated with increased risk of dementia and behavioral and psychological symptoms of dementia? A Nationwide 15-Year Follow-Up Cohort Study in Taiwan</article-title>. <source><italic toggle="yes">Front Pharmacol</italic></source>. <year>2020</year>;<volume>11</volume>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fphar.2020.00030</pub-id><pub-id pub-id-type="pmcid">PMC7033580</pub-id><pub-id pub-id-type="pmid">32116707</pub-id></mixed-citation></ref><ref id="cit0034"><label>34.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Wan</surname><given-names>FJ</given-names></string-name>, <string-name name-style="western"><surname>Chien</surname><given-names>WC</given-names></string-name>, <string-name name-style="western"><surname>Chung</surname><given-names>CH</given-names></string-name>, <string-name name-style="western"><surname>Yang</surname><given-names>YJ</given-names></string-name>, <string-name name-style="western"><surname>Tzeng</surname><given-names>NS</given-names></string-name>. <article-title>Association between traumatic spinal cord injury and affective and other psychiatric disorders&#8211;A nationwide cohort study and effects of rehabilitation therapies</article-title>. <source><italic toggle="yes">J Affect Disord</italic></source>. <year>2020</year>;<volume>265</volume>:<fpage>381</fpage>&#8211;<lpage>388</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jad.2020.01.063</pub-id><pub-id pub-id-type="pmid">32090763</pub-id></mixed-citation></ref><ref id="cit0035"><label>35.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Wang</surname><given-names>DS</given-names></string-name>, <string-name name-style="western"><surname>Chung</surname><given-names>CH</given-names></string-name>, <string-name name-style="western"><surname>Chang</surname><given-names>HA</given-names></string-name>, et al. <article-title>Association between child abuse exposure and the risk of psychiatric disorders: A nationwide cohort study in Taiwan</article-title>. <source><italic toggle="yes">Child Abuse Negl</italic></source>. <year>2020</year>;<volume>101</volume>:<fpage>104362</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.chiabu.2020.104362</pub-id><pub-id pub-id-type="pmid">31935531</pub-id></mixed-citation></ref><ref id="cit0036"><label>36.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Lin</surname><given-names>CH</given-names></string-name>, <string-name name-style="western"><surname>Chien</surname><given-names>WC</given-names></string-name>, <string-name name-style="western"><surname>Chung</surname><given-names>CH</given-names></string-name>, et al. <article-title>Increased risk of dementia in patients with genital warts: A nationwide cohort study in Taiwan</article-title>. <source><italic toggle="yes">J Dermatol</italic></source>. <year>2020</year>;<volume>47</volume>(<issue>5</issue>):<fpage>503</fpage>&#8211;<lpage>511</lpage>. doi:<pub-id pub-id-type="doi">10.1111/1346-8138.15277</pub-id><pub-id pub-id-type="pmid">32189395</pub-id></mixed-citation></ref><ref id="cit0037"><label>37.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Yeh</surname><given-names>TC</given-names></string-name>, <string-name name-style="western"><surname>Chien</surname><given-names>WC</given-names></string-name>, <string-name name-style="western"><surname>Chung</surname><given-names>CH</given-names></string-name>, et al. <article-title>Psychiatric disorders after traumatic brain injury: a Nationwide Population-Based Cohort Study and the effects of rehabilitation therapies</article-title>. <source><italic toggle="yes">Arch Phys Med Rehabil</italic></source>. <year>2020</year>;<volume>101</volume>(<issue>5</issue>):<fpage>822</fpage>&#8211;<lpage>831</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.apmr.2019.12.005</pub-id><pub-id pub-id-type="pmid">31917196</pub-id></mixed-citation></ref><ref id="cit0038"><label>38.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Tzeng</surname><given-names>NS</given-names></string-name>, <string-name name-style="western"><surname>Hsu</surname><given-names>YH</given-names></string-name>, <string-name name-style="western"><surname>Ho</surname><given-names>SY</given-names></string-name>, et al. <article-title>Is schizophrenia associated with an increased risk of chronic kidney disease? A nationwide matched-cohort study</article-title>. <source><italic toggle="yes">BMJ Open</italic></source>. <year>2015</year>;<volume>5</volume>(<issue>1</issue>):<fpage>e006777</fpage>. doi:<pub-id pub-id-type="doi">10.1136/bmjopen-2014-006777</pub-id><pub-id pub-id-type="pmcid">PMC4316552</pub-id><pub-id pub-id-type="pmid">25628048</pub-id></mixed-citation></ref><ref id="cit0039"><label>39.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Chiou</surname><given-names>YE</given-names></string-name>, <string-name name-style="western"><surname>Chien</surname><given-names>WC</given-names></string-name>, <string-name name-style="western"><surname>Chung</surname><given-names>CH</given-names></string-name>, et al. <article-title>New users of herbal medicine containing aristolochic acids and the risk of dementia in the elderly: a Nationwide, Population-Based Study in Taiwan</article-title>. <source><italic toggle="yes">Neuropsychiatr Dis Treat</italic></source>. <year>2020</year>;<volume>16</volume>:<fpage>1493</fpage>&#8211;<lpage>1504</lpage>. doi:<pub-id pub-id-type="doi">10.2147/NDT.S250659</pub-id><pub-id pub-id-type="pmid">32606702</pub-id><pub-id pub-id-type="pmcid">PMC7297452</pub-id></mixed-citation></ref><ref id="cit0040"><label>40.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Tzeng</surname><given-names>NS</given-names></string-name>, <string-name name-style="western"><surname>Chien</surname><given-names>WC</given-names></string-name>, <string-name name-style="western"><surname>Chun</surname><given-names>CH</given-names></string-name>, <string-name name-style="western"><surname>Chang</surname><given-names>HA</given-names></string-name>, <string-name name-style="western"><surname>Kao</surname><given-names>YC</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>YP</given-names></string-name>. <article-title>Association between amphetamine-related disorders and dementia-a Nationwide Cohort Study in Taiwan</article-title>. <source><italic toggle="yes">Ann Clin Transl Neurol</italic></source>. <year>2020</year>;<volume>7</volume>(<issue>8</issue>):<fpage>1284</fpage>&#8211;<lpage>1295</lpage>. doi:<pub-id pub-id-type="doi">10.1002/acn3.51113</pub-id><pub-id pub-id-type="pmid">32608133</pub-id><pub-id pub-id-type="pmcid">PMC7448166</pub-id></mixed-citation></ref><ref id="cit0041"><label>41.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>McDonald</surname><given-names>WI</given-names></string-name>, <string-name name-style="western"><surname>Compston</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Edan</surname><given-names>G</given-names></string-name>, et al. <article-title>Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis</article-title>. <source><italic toggle="yes">Ann Neurol</italic></source>. <year>2001</year>;<volume>50</volume>(<issue>1</issue>):<fpage>121</fpage>&#8211;<lpage>127</lpage>. doi:<pub-id pub-id-type="doi">10.1002/ana.1032</pub-id><pub-id pub-id-type="pmid">11456302</pub-id></mixed-citation></ref><ref id="cit0042"><label>42.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Polman</surname><given-names>CH</given-names></string-name>, <string-name name-style="western"><surname>Reingold</surname><given-names>SC</given-names></string-name>, <string-name name-style="western"><surname>Banwell</surname><given-names>B</given-names></string-name>, et al. <article-title>Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria</article-title>. <source><italic toggle="yes">Ann Neurol</italic></source>. <year>2011</year>;<volume>69</volume>(<issue>2</issue>):<fpage>292</fpage>&#8211;<lpage>302</lpage>. doi:<pub-id pub-id-type="doi">10.1002/ana.22366</pub-id><pub-id pub-id-type="pmid">21387374</pub-id><pub-id pub-id-type="pmcid">PMC3084507</pub-id></mixed-citation></ref><ref id="cit0043"><label>43.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Thompson</surname><given-names>AJ</given-names></string-name>, <string-name name-style="western"><surname>Banwell</surname><given-names>BL</given-names></string-name>, <string-name name-style="western"><surname>Barkhof</surname><given-names>F</given-names></string-name>, et al. <article-title>Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria</article-title>. <source><italic toggle="yes">Lancet Neurol</italic></source>. <year>2018</year>;<volume>17</volume>(<issue>2</issue>):<fpage>162</fpage>&#8211;<lpage>173</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S1474-4422(17)30470-2</pub-id><pub-id pub-id-type="pmid">29275977</pub-id></mixed-citation></ref><ref id="cit0044"><label>44.</label><mixed-citation publication-type="web"><collab>Ministry of Justice</collab>. <article-title>National health insurance reimbursement regulations</article-title>; <year>2019</year>. <comment>Available from:</comment><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://law.moj.gov.tw/LawClass/LawAll.aspx?pcode=L0060035">https://law.moj.gov.tw/LawClass/LawAll.aspx?pcode=L0060035</ext-link>. <date-in-citation>Accessed <month>12</month><day>18</day>, 2019</date-in-citation>.</mixed-citation></ref><ref id="cit0045"><label>45.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Tseng</surname><given-names>CC</given-names></string-name>, <string-name name-style="western"><surname>Chang</surname><given-names>SJ</given-names></string-name>, <string-name name-style="western"><surname>Tsai</surname><given-names>WC</given-names></string-name>, et al. <article-title>Increased incidence of multiple sclerosis in systemic sclerosis: A nationwide cohort study</article-title>. <source><italic toggle="yes">Prev Med</italic></source>. <year>2016</year>;<volume>84</volume>:<fpage>6</fpage>&#8211;<lpage>11</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ypmed.2015.12.006</pub-id><pub-id pub-id-type="pmid">26724518</pub-id></mixed-citation></ref><ref id="cit0046"><label>46.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Tseng</surname><given-names>CC</given-names></string-name>, <string-name name-style="western"><surname>Chang</surname><given-names>SJ</given-names></string-name>, <string-name name-style="western"><surname>Tsai</surname><given-names>WC</given-names></string-name>, et al. <article-title>Increased incidence of rheumatoid arthritis in multiple sclerosis: A nationwide cohort study</article-title>. <source><italic toggle="yes">Medicine</italic></source>. <year>2016</year>;<volume>95</volume>(<issue>26</issue>):<fpage>e3999</fpage>. doi:<pub-id pub-id-type="doi">10.1097/MD.0000000000003999</pub-id><pub-id pub-id-type="pmid">27368008</pub-id><pub-id pub-id-type="pmcid">PMC4937922</pub-id></mixed-citation></ref><ref id="cit0047"><label>47.</label><mixed-citation publication-type="web"><collab>National Health Insurance Adminitration</collab>. <article-title>Data protection and regulations, in national health insurance research database</article-title>. <comment>Available from:</comment><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://nhird.nhri.org.tw/en/Data_Protection.html">https://nhird.nhri.org.tw/en/Data_Protection.html</ext-link>. <date-in-citation>Accessed <month>12</month>, <day>9</day>, 2020</date-in-citation>.</mixed-citation></ref><ref id="cit0048"><label>48.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Chen</surname><given-names>YC</given-names></string-name>, <string-name name-style="western"><surname>Yeh</surname><given-names>HY</given-names></string-name>, <string-name name-style="western"><surname>Wu</surname><given-names>JC</given-names></string-name>, <string-name name-style="western"><surname>Haschler</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>TJ</given-names></string-name>, <string-name name-style="western"><surname>Wetter</surname><given-names>T</given-names></string-name>. <article-title>Taiwan&#8217;s National Health Insurance Research Database: administrative health care database as study object in bibliometrics</article-title>. <source><italic toggle="yes">Scientometrics</italic></source>. <year>2010</year>;<volume>86</volume>(<issue>2</issue>):<fpage>365</fpage>&#8211;<lpage>380</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s11192-010-0289-2</pub-id></mixed-citation></ref><ref id="cit0049"><label>49.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Hsiao</surname><given-names>FY</given-names></string-name>, <string-name name-style="western"><surname>Yang</surname><given-names>CL</given-names></string-name>, <string-name name-style="western"><surname>Huang</surname><given-names>YT</given-names></string-name>, <string-name name-style="western"><surname>Huang</surname><given-names>WF</given-names></string-name>. <article-title>Using Taiwan&#8217;s national health insurance research databases for pharmacoepidemiology research</article-title>. <source><italic toggle="yes">J Food Drug Anal</italic></source>. <year>2007</year>;<volume>15</volume>:<fpage>99</fpage>&#8211;<lpage>108</lpage>.</mixed-citation></ref><ref id="cit0050"><label>50.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Sung</surname><given-names>SF</given-names></string-name>, <string-name name-style="western"><surname>Hsieh</surname><given-names>CY</given-names></string-name>, <string-name name-style="western"><surname>Hu</surname><given-names>YH</given-names></string-name>. <article-title>Two decades of research using Taiwan&#8217;s national health insurance claims data: bibliometric and text mining analysis on pubmed</article-title>. <source><italic toggle="yes">J Med Internet Res</italic></source>. <year>2020</year>;<volume>22</volume>(<issue>6</issue>):<fpage>e18457</fpage>. doi:<pub-id pub-id-type="doi">10.2196/18457</pub-id><pub-id pub-id-type="pmid">32543443</pub-id><pub-id pub-id-type="pmcid">PMC7327589</pub-id></mixed-citation></ref><ref id="cit0051"><label>51.</label><mixed-citation publication-type="web"><collab>National Cheng Kung University</collab>. <article-title>Visualizing health data</article-title>; <year>2020</year>. <comment>Available from:</comment><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://visualizinghealthdata.idv.tw/?route=article/thesis">https://visualizinghealthdata.idv.tw/?route=article/thesis</ext-link>. <date-in-citation>Accessed <month>12</month><day>9</day>, 2020</date-in-citation>.</mixed-citation></ref><ref id="cit0052"><label>52.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Ramagopalan</surname><given-names>SV</given-names></string-name>, <string-name name-style="western"><surname>Dobson</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Meier</surname><given-names>UC</given-names></string-name>, <string-name name-style="western"><surname>Giovannoni</surname><given-names>G</given-names></string-name>. <article-title>Multiple sclerosis: risk factors, prodromes, and potential causal pathways</article-title>. <source><italic toggle="yes">Lancet Neurol</italic></source>. <year>2010</year>;<volume>9</volume>(<issue>7</issue>):<fpage>727</fpage>&#8211;<lpage>739</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S1474-4422(10)70094-6</pub-id><pub-id pub-id-type="pmid">20610348</pub-id></mixed-citation></ref><ref id="cit0053"><label>53.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Young</surname><given-names>CA</given-names></string-name>. <article-title>Factors predisposing to the development of multiple sclerosis</article-title>. <source><italic toggle="yes">Qjm</italic></source>. <year>2011</year>;<volume>104</volume>(<issue>5</issue>):<fpage>383</fpage>&#8211;<lpage>386</lpage>. doi:<pub-id pub-id-type="doi">10.1093/qjmed/hcr012</pub-id><pub-id pub-id-type="pmid">21382923</pub-id></mixed-citation></ref><ref id="cit0054"><label>54.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Wens</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Dalgas</surname><given-names>U</given-names></string-name>, <string-name name-style="western"><surname>Stenager</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Eijnde</surname><given-names>BO</given-names></string-name>. <article-title>Risk factors related to cardiovascular diseases and the metabolic syndrome in multiple sclerosis - a systematic review</article-title>. <source><italic toggle="yes">Mult Scler</italic></source>. <year>2013</year>;<volume>19</volume>(<issue>12</issue>):<fpage>1556</fpage>&#8211;<lpage>1564</lpage>. doi:<pub-id pub-id-type="doi">10.1177/1352458513504252</pub-id><pub-id pub-id-type="pmid">24048545</pub-id></mixed-citation></ref><ref id="cit0055"><label>55.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Belbasis</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Bellou</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Evangelou</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Ioannidis</surname><given-names>JP</given-names></string-name>, <string-name name-style="western"><surname>Tzoulaki</surname><given-names>I</given-names></string-name>. <article-title>Environmental risk factors and multiple sclerosis: an umbrella review of systematic reviews and meta-analyses</article-title>. <source><italic toggle="yes">Lancet Neurol</italic></source>. <year>2015</year>;<volume>14</volume>(<issue>3</issue>):<fpage>263</fpage>&#8211;<lpage>273</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S1474-4422(14)70267-4</pub-id><pub-id pub-id-type="pmid">25662901</pub-id></mixed-citation></ref><ref id="cit0056"><label>56.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Hou</surname><given-names>WH</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>CY</given-names></string-name>, <string-name name-style="western"><surname>Chang</surname><given-names>HH</given-names></string-name>, <string-name name-style="western"><surname>Sun</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Tsai</surname><given-names>CC</given-names></string-name>. <article-title>A population-based cohort study suggests an increased risk of multiple sclerosis incidence in patients with type 2 diabetes mellitus</article-title>. <source><italic toggle="yes">J Epidemiol</italic></source>. <year>2017</year>;<volume>27</volume>(<issue>5</issue>):<fpage>235</fpage>&#8211;<lpage>241</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.je.2016.06.006</pub-id><pub-id pub-id-type="pmid">28142047</pub-id><pub-id pub-id-type="pmcid">PMC5394222</pub-id></mixed-citation></ref><ref id="cit0057"><label>57.</label><mixed-citation publication-type="book"><collab>American Psychiatric Association</collab>. <source><italic toggle="yes">Diagnostic and Statistical Manual of Mental Disorders 4th Edition</italic></source>. <edition>4</edition> ed. <publisher-loc>USA</publisher-loc>: <publisher-name>American Psychiatric Association</publisher-name>; <year>1994</year>.</mixed-citation></ref><ref id="cit0058"><label>58.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Stein</surname><given-names>DJ</given-names></string-name>, <string-name name-style="western"><surname>Phillips</surname><given-names>KA</given-names></string-name>, <string-name name-style="western"><surname>Bolton</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Fulford</surname><given-names>KW</given-names></string-name>, <string-name name-style="western"><surname>Sadler</surname><given-names>JZ</given-names></string-name>, <string-name name-style="western"><surname>Kendler</surname><given-names>KS</given-names></string-name>. <article-title>What is a mental/psychiatric disorder? From DSM-IV to DSM-V</article-title>. <source><italic toggle="yes">Psychol Med</italic></source>. <year>2010</year>;<volume>40</volume>(<issue>11</issue>):<fpage>1759</fpage>&#8211;<lpage>1765</lpage>. doi:<pub-id pub-id-type="doi">10.1017/S0033291709992261</pub-id><pub-id pub-id-type="pmid">20624327</pub-id><pub-id pub-id-type="pmcid">PMC3101504</pub-id></mixed-citation></ref><ref id="cit0059"><label>59.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Fine</surname><given-names>JP</given-names></string-name>, <string-name name-style="western"><surname>Gray</surname><given-names>RJ</given-names></string-name>. <article-title>A proportional hazards model for the subdistribution of a competing risk</article-title>. <source><italic toggle="yes">J Am Stat Assoc</italic></source>. <year>1999</year>;<volume>94</volume>(<issue>446</issue>):<fpage>496</fpage>&#8211;<lpage>509</lpage>. doi:<pub-id pub-id-type="doi">10.1080/01621459.1999.10474144</pub-id></mixed-citation></ref><ref id="cit0060"><label>60.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Marzona</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Baviera</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Vannini</surname><given-names>T</given-names></string-name>, et al. <article-title>Risk of dementia and death in patients with atrial fibrillation: A competing risk analysis of a population-based cohort</article-title>. <source><italic toggle="yes">Int J Cardiol</italic></source>. <year>2016</year>;<volume>220</volume>:<fpage>440</fpage>&#8211;<lpage>444</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ijcard.2016.06.235</pub-id><pub-id pub-id-type="pmid">27394970</pub-id></mixed-citation></ref><ref id="cit0061"><label>61.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Degli Esposti</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Piccinni</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Sangiorgi</surname><given-names>D</given-names></string-name>, et al. <article-title>Changes in first-line injectable disease-modifying therapy for multiple sclerosis: predictors of non-adherence, switching, discontinuation, and interruption of drugs</article-title>. <source><italic toggle="yes">Neurol Sci</italic></source>. <year>2017</year>;<volume>38</volume>(<issue>4</issue>):<fpage>589</fpage>&#8211;<lpage>594</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s10072-016-2806-4</pub-id><pub-id pub-id-type="pmid">28078563</pub-id></mixed-citation></ref><ref id="cit0062"><label>62.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Duchovskiene</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Mickeviciene</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Jurkeviciene</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Dirziuviene</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Balnyte</surname><given-names>R</given-names></string-name>. <article-title>Factors associated with adherence to disease modifying therapy in multiple sclerosis: an observational survey from a referral center in Lithuania</article-title>. <source><italic toggle="yes">Mult Scler Relat Disord</italic></source>. <year>2017</year>;<volume>13</volume>:<fpage>107</fpage>&#8211;<lpage>111</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.msard.2017.02.016</pub-id><pub-id pub-id-type="pmid">28427690</pub-id></mixed-citation></ref><ref id="cit0063"><label>63.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Poder</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Ghatavi</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Fisk</surname><given-names>JD</given-names></string-name>, et al. <article-title>Social anxiety in a multiple sclerosis clinic population</article-title>. <source><italic toggle="yes">Mult Scler J</italic></source>. <year>2009</year>;<volume>15</volume>(<issue>3</issue>):<fpage>393</fpage>&#8211;<lpage>398</lpage>. doi:<pub-id pub-id-type="doi">10.1177/1352458508099143</pub-id><pub-id pub-id-type="pmid">19028833</pub-id></mixed-citation></ref><ref id="cit0064"><label>64.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Wood</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>van der Mei</surname><given-names>IA</given-names></string-name>, <string-name name-style="western"><surname>Ponsonby</surname><given-names>AL</given-names></string-name>, et al. <article-title>Prevalence and concurrence of anxiety, depression and fatigue over time in multiple sclerosis</article-title>. <source><italic toggle="yes">Mult Scler J</italic></source>. <year>2013</year>;<volume>19</volume>(<issue>2</issue>):<fpage>217</fpage>&#8211;<lpage>224</lpage>. doi:<pub-id pub-id-type="doi">10.1177/1352458512450351</pub-id><pub-id pub-id-type="pmid">22729988</pub-id></mixed-citation></ref><ref id="cit0065"><label>65.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Beiske</surname><given-names>AG</given-names></string-name>, <string-name name-style="western"><surname>Svensson</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Sandanger</surname><given-names>I</given-names></string-name>, et al. <article-title>Depression and anxiety amongst multiple sclerosis patients</article-title>. <source><italic toggle="yes">Eur J Neurol</italic></source>. <year>2008</year>;<volume>15</volume>(<issue>3</issue>):<fpage>239</fpage>&#8211;<lpage>245</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1468-1331.2007.02041.x</pub-id><pub-id pub-id-type="pmid">18215155</pub-id></mixed-citation></ref><ref id="cit0066"><label>66.</label><mixed-citation publication-type="book"><string-name name-style="western"><surname>Confavreux</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Compston</surname><given-names>A</given-names></string-name>. <chapter-title>The natural history of multiple sclerosis</chapter-title>. In: <string-name name-style="western"><surname>Compston</surname><given-names>A</given-names></string-name>, editor. <source><italic toggle="yes">McAlpine&#8217;s Multiple Sclerosis</italic></source>. <edition>4th</edition> ed. <publisher-loc>London</publisher-loc>: <publisher-name>Churchill Livingstone Elsevier</publisher-name>; <year>2006</year>:<fpage>183</fpage>&#8211;<lpage>272</lpage>.</mixed-citation></ref><ref id="cit0067"><label>67.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Prokopova</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Hlavacova</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Vlcek</surname><given-names>M</given-names></string-name>, et al. <article-title>Early cognitive impairment along with decreased stress-induced BDNF in male and female patients with newly diagnosed multiple sclerosis</article-title>. <source><italic toggle="yes">J Neuroimmunol</italic></source>. <year>2017</year>;<volume>302</volume>:<fpage>34</fpage>&#8211;<lpage>40</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jneuroim.2016.11.007</pub-id><pub-id pub-id-type="pmid">27979325</pub-id></mixed-citation></ref><ref id="cit0068"><label>68.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Upton</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Taylor</surname><given-names>C</given-names></string-name>. <article-title>What are the support needs of men with multiple sclerosis, and are they being met?</article-title><source><italic toggle="yes">Int J MS Care</italic></source>. <year>2015</year>;<volume>17</volume>(<issue>1</issue>):<fpage>9</fpage>&#8211;<lpage>12</lpage>. doi:<pub-id pub-id-type="doi">10.7224/1537-2073.2013-044</pub-id><pub-id pub-id-type="pmid">25741222</pub-id><pub-id pub-id-type="pmcid">PMC4338643</pub-id></mixed-citation></ref><ref id="cit0069"><label>69.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Lynch</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Long</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Moorhead</surname><given-names>A</given-names></string-name>. <article-title>Young men, help-seeking, and mental health services: exploring barriers and solutions</article-title>. <source><italic toggle="yes">Am J Mens Health</italic></source>. <year>2018</year>;<volume>12</volume>(<issue>1</issue>):<fpage>138</fpage>&#8211;<lpage>149</lpage>. doi:<pub-id pub-id-type="doi">10.1177/1557988315619469</pub-id><pub-id pub-id-type="pmid">27365212</pub-id><pub-id pub-id-type="pmcid">PMC5734535</pub-id></mixed-citation></ref><ref id="cit0070"><label>70.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Yousaf</surname><given-names>O</given-names></string-name>, <string-name name-style="western"><surname>Grunfeld</surname><given-names>EA</given-names></string-name>, <string-name name-style="western"><surname>Hunter</surname><given-names>MS</given-names></string-name>. <article-title>A systematic review of the factors associated with delays in medical and psychological help-seeking among men</article-title>. <source><italic toggle="yes">Health Psychol Rev</italic></source>. <year>2015</year>;<volume>9</volume>(<issue>2</issue>):<fpage>264</fpage>&#8211;<lpage>276</lpage>. doi:<pub-id pub-id-type="doi">10.1080/17437199.2013.840954</pub-id><pub-id pub-id-type="pmid">26209212</pub-id></mixed-citation></ref><ref id="cit0071"><label>71.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Cleary</surname><given-names>A</given-names></string-name>. <article-title>Help-seeking patterns and attitudes to treatment amongst men who attempted suicide</article-title>. <source><italic toggle="yes">J Ment Health</italic></source>. <year>2017</year>;<volume>26</volume>(<issue>3</issue>):<fpage>220</fpage>&#8211;<lpage>224</lpage>. doi:<pub-id pub-id-type="doi">10.3109/09638237.2016.1149800</pub-id><pub-id pub-id-type="pmid">26942340</pub-id></mixed-citation></ref><ref id="cit0072"><label>72.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Bombardier</surname><given-names>CH</given-names></string-name>, <string-name name-style="western"><surname>Blake</surname><given-names>KD</given-names></string-name>, <string-name name-style="western"><surname>Ehde</surname><given-names>DM</given-names></string-name>, <string-name name-style="western"><surname>Gibbons</surname><given-names>LE</given-names></string-name>, <string-name name-style="western"><surname>Moore</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Kraft</surname><given-names>GH</given-names></string-name>. <article-title>Alcohol and drug abuse among persons with multiple sclerosis</article-title>. <source><italic toggle="yes">Mult Scler J</italic></source>. <year>2004</year>;<volume>10</volume>(<issue>1</issue>):<fpage>35</fpage>&#8211;<lpage>40</lpage>. doi:<pub-id pub-id-type="doi">10.1191/1352458504ms989oa</pub-id><pub-id pub-id-type="pmid">14760950</pub-id></mixed-citation></ref><ref id="cit0073"><label>73.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Beier</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>D&#8217;Orio</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Spat</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Shuman</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Foley</surname><given-names>FW</given-names></string-name>. <article-title>Alcohol and substance use in multiple sclerosis</article-title>. <source><italic toggle="yes">J Neurol Sci</italic></source>. <year>2014</year>;<volume>338</volume>(<issue>1&#8211;2</issue>):<fpage>122</fpage>&#8211;<lpage>127</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jns.2013.12.029</pub-id><pub-id pub-id-type="pmid">24411661</pub-id></mixed-citation></ref><ref id="cit0074"><label>74.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Ying</surname><given-names>YH</given-names></string-name>, <string-name name-style="western"><surname>Weng</surname><given-names>YC</given-names></string-name>, <string-name name-style="western"><surname>Chang</surname><given-names>K</given-names></string-name>. <article-title>The impact of alcohol policies on alcohol-attributable diseases in Taiwan-A population-based study</article-title>. <source><italic toggle="yes">Drug Alcohol Depend</italic></source>. <year>2017</year>;<volume>180</volume>:<fpage>103</fpage>&#8211;<lpage>112</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.drugalcdep.2017.06.044</pub-id><pub-id pub-id-type="pmid">28888149</pub-id></mixed-citation></ref><ref id="cit0075"><label>75.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Tsai</surname><given-names>CP</given-names></string-name>, <string-name name-style="western"><surname>Lee</surname><given-names>CT</given-names></string-name>. <article-title>Impact of disease-modifying therapies on the survival of patients with multiple sclerosis in Taiwan, 1997&#8211;2008</article-title>. <source><italic toggle="yes">Clin Drug Investig</italic></source>. <year>2013</year>;<volume>33</volume>(<issue>9</issue>):<fpage>647</fpage>&#8211;<lpage>652</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s40261-013-0108-7</pub-id><pub-id pub-id-type="pmid">23861171</pub-id></mixed-citation></ref><ref id="cit0076"><label>76.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Chung</surname><given-names>WS</given-names></string-name>, <string-name name-style="western"><surname>Lin</surname><given-names>CL</given-names></string-name>, <string-name name-style="western"><surname>Tsai</surname><given-names>TC</given-names></string-name>, <string-name name-style="western"><surname>Hsu</surname><given-names>WH</given-names></string-name>, <string-name name-style="western"><surname>Kao</surname><given-names>CH</given-names></string-name>. <article-title>Multiple sclerosis increases the risk of venous thromboembolism: a nationwide cohort analysis</article-title>. <source><italic toggle="yes">Eur J Clin Invest</italic></source>. <year>2015</year>;<volume>45</volume>(<issue>12</issue>):<fpage>1228</fpage>&#8211;<lpage>1233</lpage>. doi:<pub-id pub-id-type="doi">10.1111/eci.12502</pub-id><pub-id pub-id-type="pmid">26186501</pub-id></mixed-citation></ref><ref id="cit0077"><label>77.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Kang</surname><given-names>JH</given-names></string-name>, <string-name name-style="western"><surname>Lin</surname><given-names>HC</given-names></string-name>. <article-title>Increased risk of multiple sclerosis after traumatic brain injury: a nationwide population-based study</article-title>. <source><italic toggle="yes">J Neurotrauma</italic></source>. <year>2012</year>;<volume>29</volume>(<issue>1</issue>):<fpage>90</fpage>&#8211;<lpage>95</lpage>. doi:<pub-id pub-id-type="doi">10.1089/neu.2011.1936</pub-id><pub-id pub-id-type="pmid">22044110</pub-id></mixed-citation></ref><ref id="cit0078"><label>78.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Kang</surname><given-names>JH</given-names></string-name>, <string-name name-style="western"><surname>Sheu</surname><given-names>JJ</given-names></string-name>, <string-name name-style="western"><surname>Kao</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Lin</surname><given-names>HC</given-names></string-name>. <article-title>Increased risk of multiple sclerosis following herpes zoster: a nationwide, population-based study</article-title>. <source><italic toggle="yes">J Infect Dis</italic></source>. <year>2011</year>;<volume>204</volume>(<issue>2</issue>):<fpage>188</fpage>&#8211;<lpage>192</lpage>. doi:<pub-id pub-id-type="doi">10.1093/infdis/jir239</pub-id><pub-id pub-id-type="pmid">21653524</pub-id></mixed-citation></ref><ref id="cit0079"><label>79.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Sun</surname><given-names>LM</given-names></string-name>, <string-name name-style="western"><surname>Lin</surname><given-names>CL</given-names></string-name>, <string-name name-style="western"><surname>Chung</surname><given-names>CJ</given-names></string-name>, <string-name name-style="western"><surname>Liang</surname><given-names>JA</given-names></string-name>, <string-name name-style="western"><surname>Sung</surname><given-names>FC</given-names></string-name>, <string-name name-style="western"><surname>Kao</surname><given-names>CH</given-names></string-name>. <article-title>Increased breast cancer risk for patients with multiple sclerosis: a nationwide population-based cohort study</article-title>. <source><italic toggle="yes">Eur J Neurol</italic></source>. <year>2014</year>;<volume>21</volume>(<issue>2</issue>):<fpage>238</fpage>&#8211;<lpage>244</lpage>. doi:<pub-id pub-id-type="doi">10.1111/ene.12267</pub-id><pub-id pub-id-type="pmid">24053223</pub-id></mixed-citation></ref><ref id="cit0080"><label>80.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Tsai</surname><given-names>CL</given-names></string-name>, <string-name name-style="western"><surname>Lee</surname><given-names>JT</given-names></string-name>, <string-name name-style="western"><surname>Lien</surname><given-names>LM</given-names></string-name>, et al. <article-title>The association between septicemia and the risk of multiple sclerosis: a Nationwide Register-based Retrospective Cohort Study in Taiwan</article-title>. <source><italic toggle="yes">QJM</italic></source>. <year>2018</year>;<volume>111</volume>(<issue>9</issue>):<fpage>605</fpage>&#8211;<lpage>611</lpage>. doi:<pub-id pub-id-type="doi">10.1093/qjmed/hcy123</pub-id><pub-id pub-id-type="pmid">29878253</pub-id></mixed-citation></ref><ref id="cit0081"><label>81.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Lai</surname><given-names>CY</given-names></string-name>, <string-name name-style="western"><surname>Huang</surname><given-names>YW</given-names></string-name>, <string-name name-style="western"><surname>Tseng</surname><given-names>CH</given-names></string-name>, <string-name name-style="western"><surname>Lin</surname><given-names>CL</given-names></string-name>, <string-name name-style="western"><surname>Sung</surname><given-names>FC</given-names></string-name>, <string-name name-style="western"><surname>Kao</surname><given-names>CH</given-names></string-name>. <article-title>Patients with carbon monoxide poisoning and subsequent dementia: a Population-Based Cohort Study</article-title>. <source><italic toggle="yes">Medicine</italic></source>. <year>2016</year>;<volume>95</volume>(<issue>1</issue>):<fpage>e2418</fpage>. doi:<pub-id pub-id-type="doi">10.1097/MD.0000000000002418</pub-id><pub-id pub-id-type="pmid">26735545</pub-id><pub-id pub-id-type="pmcid">PMC4706265</pub-id></mixed-citation></ref><ref id="cit0082"><label>82.</label><mixed-citation publication-type="web"><collab>Ministry of Justice</collab>. <article-title>National health insurance act</article-title>; <year>2017</year>. <comment>Available from:</comment><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://law.moj.gov.tw/LawClass/LawAll.aspx?pcode=L0060001">https://law.moj.gov.tw/LawClass/LawAll.aspx?pcode=L0060001</ext-link>. <date-in-citation>Accessed <month>2</month><day>3</day>, 2021</date-in-citation>.</mixed-citation></ref><ref id="cit0083"><label>83.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Murphy</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>O&#8217;Donoghue</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Counihan</surname><given-names>T</given-names></string-name>, et al. <article-title>Neuropsychiatric syndromes of multiple sclerosis</article-title>. <source><italic toggle="yes">J Neurol Neurosurg Psychiatry</italic></source>. <year>2017</year>;<volume>88</volume>(<issue>8</issue>):<fpage>697</fpage>&#8211;<lpage>708</lpage>. doi:<pub-id pub-id-type="doi">10.1136/jnnp-2016-315367</pub-id><pub-id pub-id-type="pmid">28285265</pub-id></mixed-citation></ref><ref id="cit0084"><label>84.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Konradi</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Sillivan</surname><given-names>SE</given-names></string-name>, <string-name name-style="western"><surname>Clay</surname><given-names>HB</given-names></string-name>. <article-title>Mitochondria, oligodendrocytes and inflammation in bipolar disorder: evidence from transcriptome studies points to intriguing parallels with multiple sclerosis</article-title>. <source><italic toggle="yes">Neurobiol Dis</italic></source>. <year>2012</year>;<volume>45</volume>(<issue>1</issue>):<fpage>37</fpage>&#8211;<lpage>47</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.nbd.2011.01.025</pub-id><pub-id pub-id-type="pmid">21310238</pub-id><pub-id pub-id-type="pmcid">PMC3117935</pub-id></mixed-citation></ref><ref id="cit0085"><label>85.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Chou</surname><given-names>IC</given-names></string-name>, <string-name name-style="western"><surname>Lin</surname><given-names>HC</given-names></string-name>, <string-name name-style="western"><surname>Lin</surname><given-names>CC</given-names></string-name>, <string-name name-style="western"><surname>Sung</surname><given-names>FC</given-names></string-name>, <string-name name-style="western"><surname>Kao</surname><given-names>CH</given-names></string-name>. <article-title>Tourette syndrome and risk of depression: a population-based cohort study in Taiwan</article-title>. <source><italic toggle="yes">J Dev Behav Pediatr</italic></source>. <year>2013</year>;<volume>34</volume>(<issue>3</issue>):<fpage>181</fpage>&#8211;<lpage>185</lpage>. doi:<pub-id pub-id-type="doi">10.1097/DBP.0b013e3182829f2b</pub-id><pub-id pub-id-type="pmid">23572168</pub-id></mixed-citation></ref><ref id="cit0086"><label>86.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Cheng</surname><given-names>CL</given-names></string-name>, <string-name name-style="western"><surname>Chien</surname><given-names>HC</given-names></string-name>, <string-name name-style="western"><surname>Lee</surname><given-names>CH</given-names></string-name>, <string-name name-style="western"><surname>Lin</surname><given-names>SJ</given-names></string-name>, <string-name name-style="western"><surname>Yang</surname><given-names>YH</given-names></string-name>. <article-title>Validity of in-hospital mortality data among patients with acute myocardial infarction or stroke in National Health Insurance Research Database in Taiwan</article-title>. <source><italic toggle="yes">Int J Cardiol</italic></source>. <year>2015</year>;<volume>201</volume>:<fpage>96</fpage>&#8211;<lpage>101</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ijcard.2015.07.075</pub-id><pub-id pub-id-type="pmid">26292275</pub-id></mixed-citation></ref><ref id="cit0087"><label>87.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Cheng</surname><given-names>CL</given-names></string-name>, <string-name name-style="western"><surname>Kao</surname><given-names>YH</given-names></string-name>, <string-name name-style="western"><surname>Lin</surname><given-names>SJ</given-names></string-name>, <string-name name-style="western"><surname>Lee</surname><given-names>CH</given-names></string-name>, <string-name name-style="western"><surname>Lai</surname><given-names>ML</given-names></string-name>. <article-title>Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan</article-title>. <source><italic toggle="yes">Pharmacoepidemiol Drug Saf</italic></source>. <year>2011</year>;<volume>20</volume>(<issue>3</issue>):<fpage>236</fpage>&#8211;<lpage>242</lpage>. doi:<pub-id pub-id-type="doi">10.1002/pds.2087</pub-id><pub-id pub-id-type="pmid">21351304</pub-id></mixed-citation></ref><ref id="cit0088"><label>88.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Sung</surname><given-names>SF</given-names></string-name>, <string-name name-style="western"><surname>Hsieh</surname><given-names>CY</given-names></string-name>, <string-name name-style="western"><surname>Lin</surname><given-names>HJ</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>YW</given-names></string-name>, <string-name name-style="western"><surname>Yang</surname><given-names>YH</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>CY</given-names></string-name>. <article-title>Validation of algorithms to identify stroke risk factors in patients with acute ischemic stroke, transient ischemic attack, or intracerebral hemorrhage in an administrative claims database</article-title>. <source><italic toggle="yes">Int J Cardiol</italic></source>. <year>2016</year>;<volume>215</volume>:<fpage>277</fpage>&#8211;<lpage>282</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ijcard.2016.04.069</pub-id><pub-id pub-id-type="pmid">27128546</pub-id></mixed-citation></ref><ref id="cit0089"><label>89.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Tseng</surname><given-names>HP</given-names></string-name>, <string-name name-style="western"><surname>Lin</surname><given-names>FJ</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>PT</given-names></string-name>, et al. <article-title>Derivation and validation of a discharge disposition predicting model after acute stroke</article-title>. <source><italic toggle="yes">J Stroke Cerebrovasc Dis</italic></source>. <year>2015</year>;<volume>24</volume>(<issue>6</issue>):<fpage>1179</fpage>&#8211;<lpage>1186</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jstrokecerebrovasdis.2015.01.010</pub-id><pub-id pub-id-type="pmid">25847306</pub-id></mixed-citation></ref><ref id="cit0090"><label>90.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Su</surname><given-names>VY</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>CJ</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>HK</given-names></string-name>, et al. <article-title>Sleep apnea and risk of pneumonia: a nationwide population-based study</article-title>. <source><italic toggle="yes">CMAJ</italic></source>. <year>2014</year>;<volume>186</volume>(<issue>6</issue>):<fpage>415</fpage>&#8211;<lpage>421</lpage>. doi:<pub-id pub-id-type="doi">10.1503/cmaj.131547</pub-id><pub-id pub-id-type="pmid">24591276</pub-id><pub-id pub-id-type="pmcid">PMC3971026</pub-id></mixed-citation></ref><ref id="cit0091"><label>91.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Wu</surname><given-names>CS</given-names></string-name>, <string-name name-style="western"><surname>Kuo</surname><given-names>CJ</given-names></string-name>, <string-name name-style="western"><surname>Su</surname><given-names>CH</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>SH</given-names></string-name>, <string-name name-style="western"><surname>Dai</surname><given-names>HJ</given-names></string-name>. <article-title>Using text mining to extract depressive symptoms and to validate the diagnosis of major depressive disorder from electronic health records</article-title>. <source><italic toggle="yes">J Affect Disord</italic></source>. <year>2020</year>;<volume>260</volume>:<fpage>617</fpage>&#8211;<lpage>623</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jad.2019.09.044</pub-id><pub-id pub-id-type="pmid">31541973</pub-id></mixed-citation></ref><ref id="cit0092"><label>92.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Wu</surname><given-names>CS</given-names></string-name>, <string-name name-style="western"><surname>Lai</surname><given-names>MS</given-names></string-name>, <string-name name-style="western"><surname>Gau</surname><given-names>SS</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>SC</given-names></string-name>, <string-name name-style="western"><surname>Tsai</surname><given-names>HJ</given-names></string-name>. <article-title>Concordance between patient self-reports and claims data on clinical diagnoses, medication use, and health system utilization in Taiwan</article-title>. <source><italic toggle="yes">PLoS One</italic></source>. <year>2014</year>;<volume>9</volume>(<issue>12</issue>):<fpage>e112257</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0112257</pub-id><pub-id pub-id-type="pmid">25464005</pub-id><pub-id pub-id-type="pmcid">PMC4251897</pub-id></mixed-citation></ref><ref id="cit0093"><label>93.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Yu</surname><given-names>ST</given-names></string-name>, <string-name name-style="western"><surname>Chang</surname><given-names>HY</given-names></string-name>, <string-name name-style="western"><surname>Lin</surname><given-names>MC</given-names></string-name>, <string-name name-style="western"><surname>Lin</surname><given-names>YH</given-names></string-name>. <article-title>Agreement between self-reported and health insurance claims on utilization of health care: A population study</article-title>. <source><italic toggle="yes">J Clin Epidemiol</italic></source>. <year>2009</year>;<volume>62</volume>(<issue>12</issue>):<fpage>1316</fpage>&#8211;<lpage>1322</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jclinepi.2009.01.016</pub-id><pub-id pub-id-type="pmid">19403264</pub-id></mixed-citation></ref><ref id="cit0094"><label>94.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Santabarbara</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Lopez-Anton</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>de la Camara</surname><given-names>C</given-names></string-name>, et al. <article-title>Clinically significant anxiety as a risk factor for dementia in the elderly community</article-title>. <source><italic toggle="yes">Acta Psychiatr Scand</italic></source>. <year>2019</year>;<volume>139</volume>(<issue>1</issue>):<fpage>6</fpage>&#8211;<lpage>14</lpage>. doi:<pub-id pub-id-type="doi">10.1111/acps.12966</pub-id><pub-id pub-id-type="pmid">30306539</pub-id></mixed-citation></ref><ref id="cit0095"><label>95.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Santabarbara</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Villagrasa</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Lopez-Anton</surname><given-names>R</given-names></string-name>, et al. <article-title>Clinically relevant anxiety and risk of Alzheimer&#8217;s disease in an elderly community sample: 4.5 years of follow-up</article-title>. <source><italic toggle="yes">J Affect Disord</italic></source>. <year>2019</year>;<volume>250</volume>:<fpage>16</fpage>&#8211;<lpage>20</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jad.2019.02.050</pub-id><pub-id pub-id-type="pmid">30825716</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>